https://blogpharma.com/ hourly 1.0 https://blogpharma.com/about monthly 0.5 https://blogpharma.com/privacy yearly 0.3 https://blogpharma.com/terms yearly 0.3 https://blogpharma.com/category/Research hourly 0.7 https://blogpharma.com/category/Regulatory hourly 0.7 https://blogpharma.com/category/Industry%20News hourly 0.7 https://blogpharma.com/category/Biotech hourly 0.7 https://blogpharma.com/category/Drug%20Approvals hourly 0.7 https://blogpharma.com/category/Clinical%20Trials hourly 0.7 https://blogpharma.com/category/Mergers%20%26%20Acquisitions hourly 0.7 https://blogpharma.com/category/Manufacturing hourly 0.7 https://blogpharma.com/article/banana-berry-combinations-impair-flavanol-absorption-study-finds-7f7689 2026-05-24 weekly 0.8 https://blogpharma.com/article/duke-research-shows-mitochondrial-therapy-may-reverse-chronic-nerve-pain-656a25 2026-05-24 weekly 0.8 https://blogpharma.com/article/ai-mining-reddit-data-uncovers-unreported-glp-1-adverse-events-925f16 2026-05-24 weekly 0.8 https://blogpharma.com/article/semaglutide-weight-loss-drug-flagged-for-rare-vision-loss-risk-ce733b 2026-05-23 weekly 0.8 https://blogpharma.com/article/who-assembly-tackles-global-health-priorities-amid-evolving-threats-5b1c9d 2026-05-23 weekly 0.8 https://blogpharma.com/article/leadership-shake-up-at-nih-lillys-glp-1-triple-therapy-gains-momentum-ac21ac 2026-05-23 weekly 0.8 https://blogpharma.com/article/who-assembly-tackles-global-health-priorities-as-nations-convene-f1ecec 2026-05-22 weekly 0.8 https://blogpharma.com/article/parabilis-launches-ipo-push-following-major-regeneron-deal-cada99 2026-05-22 weekly 0.8 https://blogpharma.com/article/gilead-gains-fda-nod-for-hepatitis-d-therapy-after-manufacturing-overhaul-7821d8 2026-05-22 weekly 0.8 https://blogpharma.com/article/cholesterol-transport-enzymes-emerge-as-cancer-growth-target-378699 2026-05-22 weekly 0.8 https://blogpharma.com/article/ai-protein-design-platform-targets-gpcrs-as-new-drug-class-49a8d8 2026-05-22 weekly 0.8 https://blogpharma.com/article/engineered-gut-organoids-achieve-self-innervation-and-scale-up-potential-b556b1 2026-05-22 weekly 0.8 https://blogpharma.com/article/republican-pressure-mounts-on-china-biotech-investment-restrictions-80685e 2026-05-22 weekly 0.8 https://blogpharma.com/article/fda-clears-first-ever-therapy-for-chronic-hepatitis-delta-infection-76ce2c 2026-05-22 weekly 0.8 https://blogpharma.com/article/astrazeneca-breast-cancer-drug-clears-europe-amid-fda-skepticism-eb1820 2026-05-22 weekly 0.8 https://blogpharma.com/article/utah-ai-prescription-renewal-program-shows-early-promise-86e36f 2026-05-22 weekly 0.8 https://blogpharma.com/article/ai-scientists-gain-ground-as-biotech-dealmaking-and-ip-disputes-heat-up-3e8a0f 2026-05-22 weekly 0.8 https://blogpharma.com/article/major-cancer-drug-data-previewed-ahead-of-asco-2026-e231fc 2026-05-22 weekly 0.8 https://blogpharma.com/article/daiichi-sankyo-astrazeneca-win-first-line-tnbc-nod-for-datroway-99acf3 2026-05-22 weekly 0.8 https://blogpharma.com/article/who-declares-ebola-bundibugyo-outbreak-international-health-emergency-e09a88 2026-05-22 weekly 0.8 https://blogpharma.com/article/cvc-gbl-launch-recordati-bid-sobi-advances-gout-candidate-df7c57 2026-05-22 weekly 0.8 https://blogpharma.com/article/biogen-and-denali-halt-joint-parkinsons-program-after-trial-setback-571fb1 2026-05-22 weekly 0.8 https://blogpharma.com/article/third-party-logistics-providers-upgrade-infrastructure-amid-regulatory-pressures-af29d6 2026-05-22 weekly 0.8 https://blogpharma.com/article/regulators-diverge-on-astrazenecas-breast-cancer-candidate-09d2df 2026-05-22 weekly 0.8 https://blogpharma.com/article/biogen-denali-parkinsons-candidate-fails-to-meet-primary-trial-endpoint-f97caa 2026-05-22 weekly 0.8 https://blogpharma.com/article/health-ai-startup-pursues-free-service-model-to-build-market-share-55a89c 2026-05-22 weekly 0.8 https://blogpharma.com/article/novartis-seeks-broader-applications-for-aviditys-muscle-targeting-technology-df9c8c 2026-05-22 weekly 0.8 https://blogpharma.com/article/cvc-led-group-pursues-recordati-delisting-in-11-5b-deal-06e93a 2026-05-22 weekly 0.8 https://blogpharma.com/article/nordic-biotech-leaders-convene-at-copenhagen-partnership-summit-83b801 2026-05-22 weekly 0.8 https://blogpharma.com/article/paradigm-health-spire-platform-targets-post-approval-oncology-research-77c8aa 2026-05-22 weekly 0.8 https://blogpharma.com/article/biogen-and-denali-halt-parkinsons-program-after-phase-2b-setback-e5763b 2026-05-22 weekly 0.8 https://blogpharma.com/article/gait-modification-shows-promise-as-non-pharmacological-osteoarthritis-treatment-520608 2026-05-22 weekly 0.8 https://blogpharma.com/article/asco-meeting-spotlights-next-generation-oncology-candidates-a23a7e 2026-05-22 weekly 0.8 https://blogpharma.com/article/amgen-cfo-peter-griffith-announces-retirement-dittrich-named-successor-a9e288 2026-05-22 weekly 0.8 https://blogpharma.com/article/syphilis-gonorrhea-surge-strains-european-public-health-response-d67bbc 2026-05-22 weekly 0.8 https://blogpharma.com/article/eli-lillys-triple-agonist-shows-strong-weight-loss-but-safety-questions-emerge-e08bec 2026-05-22 weekly 0.8 https://blogpharma.com/article/gilead-completes-5b-acquisition-of-german-biotech-tubulis-126239 2026-05-22 weekly 0.8 https://blogpharma.com/article/biogen-denali-share-phase-iib-results-for-parkinsons-candidate-4fdd58 2026-05-22 weekly 0.8 https://blogpharma.com/article/medtech-sector-convenes-to-address-evolving-trial-landscape-00c750 2026-05-22 weekly 0.8 https://blogpharma.com/article/merck-initiates-phase-iii-trial-for-ceacam5-targeted-cancer-therapy-262c7b 2026-05-22 weekly 0.8 https://blogpharma.com/article/concept-life-sciences-taps-openbench-for-risk-sharing-drug-discovery-model-3eb90f 2026-05-22 weekly 0.8 https://blogpharma.com/article/genentech-funds-academic-research-backing-industry-stance-on-drug-pricing-7b633c 2026-05-22 weekly 0.8 https://blogpharma.com/article/ai-and-human-data-integration-drive-drug-discovery-innovation-124eaf 2026-05-22 weekly 0.8 https://blogpharma.com/article/glp-1-drugs-show-potential-beyond-weight-loss-in-arthritis-711926 2026-05-22 weekly 0.8 https://blogpharma.com/article/senescent-cells-show-dual-role-reshaping-anti-aging-drug-strategies-f06590 2026-05-22 weekly 0.8 https://blogpharma.com/article/ai-designed-miniproteins-unlock-precision-control-of-gpcr-signaling-07109f 2026-05-21 weekly 0.8 https://blogpharma.com/article/kelun-reports-phase-3-lung-cancer-win-for-merck-backed-adc-a0c97a 2026-05-21 weekly 0.8 https://blogpharma.com/article/multiple-pharmas-present-head-and-neck-cancer-data-at-asco-707ed3 2026-05-21 weekly 0.8 https://blogpharma.com/article/biontech-bms-and-pfizer-3sbio-unveil-fresh-vegf-bispecific-data-0de044 2026-05-21 weekly 0.8 https://blogpharma.com/article/merck-kelun-combo-shows-strong-efficacy-in-lung-cancer-phase-3-92aa1c 2026-05-21 weekly 0.8 https://blogpharma.com/article/who-assembly-tackles-global-health-priorities-on-day-two-e72908 2026-05-21 weekly 0.8 https://blogpharma.com/article/bio-it-world-marks-quarter-century-with-rare-disease-focus-e0dc50 2026-05-21 weekly 0.8 https://blogpharma.com/article/who-assembly-tackles-global-health-priorities-on-day-two-9f3ebd 2026-05-21 weekly 0.8 https://blogpharma.com/article/ucla-team-engineers-car-t-cells-to-combat-glioblastoma-heterogeneity-3bd91c 2026-05-21 weekly 0.8 https://blogpharma.com/article/mount-sinai-ai-model-maps-gene-interactions-across-cellular-contexts-c22034 2026-05-21 weekly 0.8 https://blogpharma.com/article/biotech-coalition-orchestrated-behind-scenes-push-against-fda-leadership-cb8d29 2026-05-21 weekly 0.8 https://blogpharma.com/article/wacker-launches-early-stage-contract-research-unit-for-gene-therapies-999cad 2026-05-21 weekly 0.8 https://blogpharma.com/article/immunovant-stock-gains-ground-on-arthritis-trial-results-3c0aec 2026-05-21 weekly 0.8 https://blogpharma.com/article/ra-capital-raises-75m-through-biotech-focused-spac-a4f22d 2026-05-21 weekly 0.8 https://blogpharma.com/article/chinese-oncology-players-set-major-asco-presence-ahead-of-key-readouts-596fd4 2026-05-21 weekly 0.8 https://blogpharma.com/article/gilead-expands-disease-elimination-push-with-who-leishmaniasis-pledge-30a8a6 2026-05-21 weekly 0.8 https://blogpharma.com/article/cruise-ship-outbreak-raises-hantavirus-infection-concerns-df03de 2026-05-21 weekly 0.8 https://blogpharma.com/article/biomarins-voxzogo-succeeds-in-hypochondroplasia-expansion-study-113c71 2026-05-21 weekly 0.8 https://blogpharma.com/article/biomarin-pursues-label-expansion-for-voxzogo-in-short-stature-f3282a 2026-05-21 weekly 0.8 https://blogpharma.com/article/incyte-bolsters-drug-discovery-engine-with-multiple-ai-partnerships-104479 2026-05-21 weekly 0.8 https://blogpharma.com/article/remepy-advances-digital-drug-combo-to-phase-iii-after-parkinsons-results-1b0336 2026-05-21 weekly 0.8 https://blogpharma.com/article/lillys-retatrutide-demonstrates-weight-loss-efficacy-in-late-stage-trial-b16296 2026-05-21 weekly 0.8 https://blogpharma.com/article/lillys-next-generation-obesity-drug-shows-promise-but-safety-concerns-emerge-7f43c2 2026-05-21 weekly 0.8 https://blogpharma.com/article/glp-1-drugs-show-major-cardiovascular-benefits-beyond-weight-loss-fefc2a 2026-05-21 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-explores-texas-expansion-as-novartis-seeks-campus-changes-219163 2026-05-21 weekly 0.8 https://blogpharma.com/article/bristol-myers-sharpens-focus-on-neuroscience-with-alzheimers-strategy-a5c7fa 2026-05-21 weekly 0.8 https://blogpharma.com/article/financial-clarity-emerges-as-critical-factor-for-trial-site-performance-dab9bb 2026-05-21 weekly 0.8 https://blogpharma.com/article/lilly-maintains-edge-in-late-stage-obesity-drug-race-d3f8a0 2026-05-21 weekly 0.8 https://blogpharma.com/article/lillys-retatrutide-achieves-bariatric-level-weight-loss-amid-safety-concerns-cd7ca2 2026-05-21 weekly 0.8 https://blogpharma.com/article/jupiter-endovascular-achieves-trial-goals-for-pe-treatment-device-0d37b0 2026-05-21 weekly 0.8 https://blogpharma.com/article/eli-lilly-acquires-engage-bio-for-202m-bolsters-gene-delivery-portfolio-10da1f 2026-05-21 weekly 0.8 https://blogpharma.com/article/pfizers-25-valent-pneumococcal-vaccine-shows-promise-in-infants-1051ff 2026-05-21 weekly 0.8 https://blogpharma.com/article/fujifilm-expands-us-cell-therapy-footprint-with-madison-manufacturing-hub-b27199 2026-05-21 weekly 0.8 https://blogpharma.com/article/obesity-drugs-and-ip-challenges-shape-first-quarter-pharma-earnings-658d95 2026-05-21 weekly 0.8 https://blogpharma.com/article/european-union-records-uptick-in-multinational-trial-launches-during-first-quart-b3ab60 2026-05-21 weekly 0.8 https://blogpharma.com/article/genetic-variant-linked-to-emphysema-development-in-copd-patients-3afc50 2026-05-21 weekly 0.8 https://blogpharma.com/article/trikafta-maintains-benefits-in-extended-cystic-fibrosis-trial-6390fa 2026-05-21 weekly 0.8 https://blogpharma.com/article/trikafta-sustains-lung-function-gains-over-48-week-study-period-26716d 2026-05-21 weekly 0.8 https://blogpharma.com/article/fragmented-it-systems-undermine-clinical-trial-data-integrity-913d9a 2026-05-21 weekly 0.8 https://blogpharma.com/article/haya-advances-htx-001-into-human-testing-with-first-cohort-dosed-b6b309 2026-05-21 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-deploys-anthropics-claude-across-operations-1e5cb0 2026-05-21 weekly 0.8 https://blogpharma.com/article/computational-methods-boost-prime-editor-efficiency-through-protein-redesign-091c6c 2026-05-21 weekly 0.8 https://blogpharma.com/article/fujifilm-cellular-dynamics-expands-wisconsin-operations-with-new-facility-097a66 2026-05-20 weekly 0.8 https://blogpharma.com/article/eli-lilly-partners-with-cdd-to-embed-ai-models-in-drug-discovery-platform-2a560b 2026-05-20 weekly 0.8 https://blogpharma.com/article/ai-framework-advances-prediction-of-rna-splicing-patterns-239ace 2026-05-20 weekly 0.8 https://blogpharma.com/article/san-diego-biotech-campfield-lands-180m-in-series-a-funding-328a02 2026-05-20 weekly 0.8 https://blogpharma.com/article/chinese-pharma-poised-for-global-expansion-within-half-decade-94933d 2026-05-20 weekly 0.8 https://blogpharma.com/article/glp-1-wave-reshapes-how-pharma-engages-patients-directly-dda12a 2026-05-20 weekly 0.8 https://blogpharma.com/article/sanofi-regenerons-copd-candidate-faces-headwinds-after-trial-setback-070413 2026-05-20 weekly 0.8 https://blogpharma.com/article/metabolite-patterns-may-guide-omalizumab-selection-in-severe-asthma-3e5746 2026-05-20 weekly 0.8 https://blogpharma.com/article/cell-therapy-makers-push-for-manufacturing-standardization-despite-product-diver-884343 2026-05-20 weekly 0.8 https://blogpharma.com/article/johns-hopkins-engineers-modular-antibodies-to-streamline-adc-manufacturing-a63bbf 2026-05-20 weekly 0.8 https://blogpharma.com/article/mixed-reality-platform-tackles-biomanufacturing-training-gap-e1e39a 2026-05-20 weekly 0.8 https://blogpharma.com/article/manufacturing-technologies-poised-to-tackle-global-organ-shortage-0530d8 2026-05-20 weekly 0.8 https://blogpharma.com/article/parabilis-eyes-public-markets-after-800m-raise-5ef8fd 2026-05-20 weekly 0.8 https://blogpharma.com/article/bristol-myers-expands-ai-capabilities-through-anthropic-partnership-c34cf0 2026-05-20 weekly 0.8 https://blogpharma.com/article/israel-emerges-as-hub-for-clinical-research-and-trial-activity-ca4c84 2026-05-20 weekly 0.8 https://blogpharma.com/article/former-acceleron-team-starts-oorja-to-develop-ipf-therapeutics-0f6d6b 2026-05-20 weekly 0.8 https://blogpharma.com/article/pfizers-25-valent-pneumococcal-vaccine-outperforms-prevnar-20-in-trial-2e9c8f 2026-05-20 weekly 0.8 https://blogpharma.com/article/pharmaceutical-firms-tighten-intellectual-property-protections-amid-rising-chine-dd0b8f 2026-05-20 weekly 0.8 https://blogpharma.com/article/who-assembly-tackles-global-health-priorities-in-may-discussions-992e7b 2026-05-20 weekly 0.8 https://blogpharma.com/article/immunovant-shows-strength-in-autoimmune-arthritis-wave-rna-program-progresses-6a0ffd 2026-05-20 weekly 0.8 https://blogpharma.com/article/major-healthcare-investment-platforms-consolidate-to-create-global-powerhouse-eb0e74 2026-05-20 weekly 0.8 https://blogpharma.com/article/fetal-gene-therapy-advances-prompt-fresh-debate-on-germline-editing-410154 2026-05-20 weekly 0.8 https://blogpharma.com/article/biotech-investors-shrug-off-political-risk-as-fda-leadership-shifts-97aac3 2026-05-20 weekly 0.8 https://blogpharma.com/article/fda-cracks-down-on-disguised-tobacco-products-in-retail-channels-e4a761 2026-05-20 weekly 0.8 https://blogpharma.com/article/pipeline-advances-suggest-new-era-for-pattern-hair-loss-therapy-2b75d9 2026-05-20 weekly 0.8 https://blogpharma.com/article/novel-enzyme-idol-emerges-as-potential-alzheimers-intervention-target-f4cfea 2026-05-20 weekly 0.8 https://blogpharma.com/article/uk-launches-framework-to-boost-cell-and-gene-therapy-trials-df3863 2026-05-20 weekly 0.8 https://blogpharma.com/article/who-assembly-honors-six-public-health-leaders-for-primary-care-advances-ffd2f8 2026-05-20 weekly 0.8 https://blogpharma.com/article/parabilis-announces-ipo-as-biotech-listing-momentum-accelerates-45f610 2026-05-20 weekly 0.8 https://blogpharma.com/article/gho-capital-and-cbc-group-combine-to-create-21b-healthcare-fund-7d18fb 2026-05-20 weekly 0.8 https://blogpharma.com/article/chinas-trial-momentum-accelerates-as-immunology-studies-surge-9221bf 2026-05-20 weekly 0.8 https://blogpharma.com/article/china-accelerates-trial-momentum-as-immunology-captures-sponsor-focus-1d074a 2026-05-20 weekly 0.8 https://blogpharma.com/article/takeda-to-appeal-885m-pay-for-delay-verdict-7f8c1d 2026-05-20 weekly 0.8 https://blogpharma.com/article/relay-therapeutics-shares-early-phase-ii-data-for-pik3ca-vascular-disease-candid-4427bd 2026-05-20 weekly 0.8 https://blogpharma.com/article/qiagen-taps-nvidia-computing-to-accelerate-ai-powered-drug-discovery-c3aaf7 2026-05-20 weekly 0.8 https://blogpharma.com/article/biomarins-bmn-401-achieves-one-primary-goal-in-pediatric-enpp1-trial-a88eb8 2026-05-20 weekly 0.8 https://blogpharma.com/article/serb-acquires-idefirix-commercialization-rights-in-133-6m-deal-65d66e 2026-05-20 weekly 0.8 https://blogpharma.com/article/first-in-human-trial-participant-recalls-early-gleevec-experience-2d9dc9 2026-05-20 weekly 0.8 https://blogpharma.com/article/swedish-biotech-firms-establish-competitive-edge-in-life-sciences-7fac6c 2026-05-20 weekly 0.8 https://blogpharma.com/article/digital-protocols-poised-to-transform-clinical-trial-data-management-dcd885 2026-05-20 weekly 0.8 https://blogpharma.com/article/eli-lilly-acquires-engage-bio-to-bolster-non-viral-gene-therapy-platform-6bc631 2026-05-20 weekly 0.8 https://blogpharma.com/article/chinas-rise-and-tech-innovation-drive-trial-landscape-shifts-6dfcdb 2026-05-20 weekly 0.8 https://blogpharma.com/article/vitamin-d-deficiency-linked-to-severe-post-surgical-pain-d1e426 2026-05-20 weekly 0.8 https://blogpharma.com/article/regeneron-partners-with-parabilis-on-novel-antibody-peptide-conjugates-56046f 2026-05-20 weekly 0.8 https://blogpharma.com/article/engineered-rna-motifs-boost-prime-editing-efficiency-fc6f6a 2026-05-20 weekly 0.8 https://blogpharma.com/article/next-generation-antivenoms-face-commercialization-hurdles-b88bd4 2026-05-20 weekly 0.8 https://blogpharma.com/article/golgi-proteins-control-rtk-trafficking-offering-cancer-therapy-angle-259e27 2026-05-19 weekly 0.8 https://blogpharma.com/article/virginia-governor-blocks-drug-cost-control-panel-initiative-f1c40b 2026-05-19 weekly 0.8 https://blogpharma.com/article/gut-bacteria-deploy-epigenetic-flexibility-to-survive-disruptions-a567c4 2026-05-19 weekly 0.8 https://blogpharma.com/article/trumprx-expands-generic-drug-catalog-to-over-600-offerings-9a1f95 2026-05-19 weekly 0.8 https://blogpharma.com/article/kraig-biocraft-develops-immortalized-silk-gland-cell-platform-cb3429 2026-05-19 weekly 0.8 https://blogpharma.com/article/paragon-spins-out-migraine-unit-via-public-market-reverse-merger-c04507 2026-05-19 weekly 0.8 https://blogpharma.com/article/former-acceleron-executives-launch-ipf-focused-biotech-with-30m-series-a-751cfd 2026-05-19 weekly 0.8 https://blogpharma.com/article/deepmind-and-edison-launch-automated-ai-research-platforms-ef010d 2026-05-19 weekly 0.8 https://blogpharma.com/article/canadian-medical-societies-face-gaps-in-conflict-of-interest-oversight-975539 2026-05-19 weekly 0.8 https://blogpharma.com/article/cassidys-primary-defeat-reshapes-health-policy-landscape-2553c1 2026-05-19 weekly 0.8 https://blogpharma.com/article/biomarins-acquired-therapy-stumbles-in-enpp1-deficiency-trial-d160eb 2026-05-19 weekly 0.8 https://blogpharma.com/article/industry-leaders-debate-consumer-health-priorities-at-ft-summit-733000 2026-05-19 weekly 0.8 https://blogpharma.com/article/novo-nordisk-restructures-r-d-to-accelerate-drug-discovery-pipeline-5b1047 2026-05-19 weekly 0.8 https://blogpharma.com/article/waves-rna-editor-targets-monthly-dosing-schedule-for-aatd-fc895f 2026-05-19 weekly 0.8 https://blogpharma.com/article/migraine-focused-spinout-eyes-public-listing-via-reverse-merger-7a8146 2026-05-19 weekly 0.8 https://blogpharma.com/article/full-life-technologies-secures-150m-in-series-d-funding-round-a70c58 2026-05-19 weekly 0.8 https://blogpharma.com/article/boston-scientific-advances-ivl-catheter-toward-fda-review-bfbb19 2026-05-19 weekly 0.8 https://blogpharma.com/article/uk-secures-japanese-antiviral-stockpile-to-strengthen-hantavirus-defenses-e1e63e 2026-05-19 weekly 0.8 https://blogpharma.com/article/lilly-tops-dual-r-d-rankings-in-annual-pharma-innovation-analysis-99272e 2026-05-19 weekly 0.8 https://blogpharma.com/article/supreme-court-rebuffs-pharma-challenge-to-medicare-drug-pricing-8f9076 2026-05-19 weekly 0.8 https://blogpharma.com/article/ras-inhibitor-pipeline-expands-beyond-early-successes-3e2c64 2026-05-19 weekly 0.8 https://blogpharma.com/article/relays-experimental-drug-demonstrates-potential-in-vascular-anomaly-treatment-c2aa02 2026-05-19 weekly 0.8 https://blogpharma.com/article/virtual-nutrition-platform-nourish-valued-at-1-75b-after-funding-round-160eb7 2026-05-19 weekly 0.8 https://blogpharma.com/article/eli-lilly-captures-top-rankings-in-pharma-innovation-and-r-d-metrics-28c16c 2026-05-19 weekly 0.8 https://blogpharma.com/article/relays-pi3k-inhibitor-shows-promise-in-vascular-disorder-trial-dfb0b4 2026-05-19 weekly 0.8 https://blogpharma.com/article/vincentage-advances-oral-glp-1-candidate-with-phase-iii-china-success-e779e8 2026-05-19 weekly 0.8 https://blogpharma.com/article/biomarin-enzyme-therapy-misses-primary-endpoint-in-rare-disease-study-4a3f53 2026-05-19 weekly 0.8 https://blogpharma.com/article/design-therapeutics-shares-early-data-on-friedreich-ataxia-candidate-b5c0cb 2026-05-19 weekly 0.8 https://blogpharma.com/article/fda-grants-breakthrough-designation-to-vertanicals-pain-therapy-e0f93d 2026-05-19 weekly 0.8 https://blogpharma.com/article/triveni-bio-advances-first-in-class-bispecific-into-human-testing-fcb86f 2026-05-19 weekly 0.8 https://blogpharma.com/article/regeneron-invests-2-32b-in-parabilis-for-antibody-drug-platform-497451 2026-05-19 weekly 0.8 https://blogpharma.com/article/sterilization-validation-critical-for-co2-incubator-shaker-contamination-control-ca19f8 2026-05-19 weekly 0.8 https://blogpharma.com/article/gene-design-strategies-vary-widely-for-antibody-production-efficiency-a2c42d 2026-05-19 weekly 0.8 https://blogpharma.com/article/ai-model-enables-unbiased-peptide-sequencing-without-prior-knowledge-86b448 2026-05-19 weekly 0.8 https://blogpharma.com/article/maryland-sets-price-cap-on-ozempic-targeting-274-monthly-cost-79d9e0 2026-05-18 weekly 0.8 https://blogpharma.com/article/white-house-expands-trumprx-with-generic-drug-catalog-partnership-3a812d 2026-05-18 weekly 0.8 https://blogpharma.com/article/transcriptomic-study-compares-mouse-models-of-ms-myelin-damage-11d8da 2026-05-18 weekly 0.8 https://blogpharma.com/article/ucla-research-points-to-epac2-as-potential-fxs-treatment-target-14cb89 2026-05-18 weekly 0.8 https://blogpharma.com/article/university-of-bath-funds-organ-on-chip-platform-for-diabetes-dementia-link-1bb918 2026-05-18 weekly 0.8 https://blogpharma.com/article/who-assembly-convenes-in-geneva-with-new-leadership-17fe72 2026-05-18 weekly 0.8 https://blogpharma.com/article/amgen-defends-tavneos-despite-mounting-global-safety-concerns-467b22 2026-05-18 weekly 0.8 https://blogpharma.com/article/congressional-release-of-fda-covid-vaccine-mortality-study-breaks-agency-silence-6b9e1e 2026-05-18 weekly 0.8 https://blogpharma.com/article/astrazeneca-gains-fda-clearance-for-new-hypertension-treatment-5ab6c8 2026-05-18 weekly 0.8 https://blogpharma.com/article/protaras-cell-therapy-demonstrates-sustained-response-in-bladder-cancer-study-b95281 2026-05-18 weekly 0.8 https://blogpharma.com/article/astrazeneca-wins-fda-clearance-for-novel-hypertension-treatment-722920 2026-05-18 weekly 0.8 https://blogpharma.com/article/astrazeneca-to-unveil-early-azd3470-data-in-hodgkin-lymphoma-679d39 2026-05-18 weekly 0.8 https://blogpharma.com/article/who-elevates-ebola-crisis-to-international-emergency-status-5be387 2026-05-18 weekly 0.8 https://blogpharma.com/article/mercks-licensed-china-adc-shows-promise-in-endometrial-cancer-study-55b68c 2026-05-18 weekly 0.8 https://blogpharma.com/article/msds-experimental-therapy-achieves-endometrial-cancer-trial-goals-215ae1 2026-05-18 weekly 0.8 https://blogpharma.com/article/regeneron-invests-in-parabilis-platform-to-diversify-beyond-struggling-oncology-f7f3f8 2026-05-18 weekly 0.8 https://blogpharma.com/article/chronic-hepatitis-b-projected-to-challenge-healthcare-systems-293096 2026-05-18 weekly 0.8 https://blogpharma.com/article/design-therapeutics-advances-friedreich-ataxia-program-with-phase-data-10431a 2026-05-18 weekly 0.8 https://blogpharma.com/article/fda-reshuffles-drug-review-leadership-in-new-management-shift-f8f209 2026-05-18 weekly 0.8 https://blogpharma.com/article/mercks-kelun-partnership-yields-early-phase-3-adc-success-a430cc 2026-05-18 weekly 0.8 https://blogpharma.com/article/supreme-court-declines-to-review-medicare-negotiation-legal-challenges-6d6140 2026-05-18 weekly 0.8 https://blogpharma.com/article/supreme-court-declines-to-review-pharma-industry-ira-challenges-d97cc9 2026-05-18 weekly 0.8 https://blogpharma.com/article/who-honors-four-leaders-with-global-health-achievement-award-09d492 2026-05-18 weekly 0.8 https://blogpharma.com/article/u-s-biotech-faces-reckoning-over-china-drug-dependencies-71f7b2 2026-05-18 weekly 0.8 https://blogpharma.com/article/emerging-antidepressants-show-promise-against-treatment-resistant-depression-a6ed1e 2026-05-18 weekly 0.8 https://blogpharma.com/article/obesity-treatment-paradigm-shifts-to-organ-level-focus-ce6303 2026-05-18 weekly 0.8 https://blogpharma.com/article/regenerons-lag-3-combo-fails-to-beat-mercks-keytruda-in-melanoma-e113cf 2026-05-18 weekly 0.8 https://blogpharma.com/article/regenerons-lag-3-candidate-fails-late-stage-melanoma-study-14acd6 2026-05-18 weekly 0.8 https://blogpharma.com/article/ipsens-botulinum-toxin-candidate-shows-extended-duration-in-wrinkle-study-a89e3e 2026-05-18 weekly 0.8 https://blogpharma.com/article/astrazeneca-wins-fda-approval-for-baxdrostat-hypertension-drug-a6752a 2026-05-18 weekly 0.8 https://blogpharma.com/article/fda-cder-official-departs-amid-hhs-leadership-reorganization-3f174f 2026-05-18 weekly 0.8 https://blogpharma.com/article/boehringer-gains-japanese-clearance-for-nerandomilast-in-pulmonary-fibrosis-66fbe9 2026-05-18 weekly 0.8 https://blogpharma.com/article/global-ovarian-cancer-trials-face-new-complexity-challenges-07f03c 2026-05-18 weekly 0.8 https://blogpharma.com/article/global-ovarian-cancer-trials-face-new-operational-hurdles-3da70f 2026-05-18 weekly 0.8 https://blogpharma.com/article/mature-drug-portfolios-gain-new-economics-via-outsourcing-strategy-397005 2026-05-18 weekly 0.8 https://blogpharma.com/article/china-partnerships-fracture-biotechs-traditionally-united-front-52511e 2026-05-18 weekly 0.8 https://blogpharma.com/article/regeneron-misses-primary-endpoint-in-melanoma-combination-trial-29b5a6 2026-05-18 weekly 0.8 https://blogpharma.com/article/enhertu-gains-fda-nod-for-early-her2-positive-breast-cancer-b3e8b1 2026-05-18 weekly 0.8 https://blogpharma.com/article/regenxbio-stock-plunges-on-dmd-gene-therapy-regulatory-hurdle-0b472a 2026-05-18 weekly 0.8 https://blogpharma.com/article/researchers-develop-electromagnetic-gene-switch-for-in-vivo-control-0f4c70 2026-05-18 weekly 0.8 https://blogpharma.com/article/mitocatch-platform-delivers-functional-mitochondria-to-diseased-tissue-1ca8b9 2026-05-18 weekly 0.8 https://blogpharma.com/article/nature-biotech-publishes-correction-on-rna-splicing-discovery-study-9b56bd 2026-05-18 weekly 0.8 https://blogpharma.com/article/researchers-engineer-b-cell-immunity-using-stem-cell-programming-43a30c 2026-05-18 weekly 0.8 https://blogpharma.com/article/intellia-advances-in-vivo-crispr-therapy-toward-fda-review-b72df6 2026-05-18 weekly 0.8 https://blogpharma.com/article/global-biotech-sector-reports-mixed-progress-across-key-regions-8d0172 2026-05-18 weekly 0.8 https://blogpharma.com/article/biotech-approaches-target-crop-protection-without-synthetic-pesticides-eb6274 2026-05-18 weekly 0.8 https://blogpharma.com/article/united-kingdom-approves-first-crispr-modified-crop-variety-7847dd 2026-05-18 weekly 0.8 https://blogpharma.com/article/uk-health-groups-sue-over-us-pharma-trade-deal-terms-324eb8 2026-05-17 weekly 0.8 https://blogpharma.com/article/watermelon-emerges-as-functional-food-with-cardiovascular-benefits-14d04a 2026-05-17 weekly 0.8 https://blogpharma.com/article/engineered-nanoparticles-restore-cognitive-function-in-alzheimers-mouse-models-0b75a3 2026-05-17 weekly 0.8 https://blogpharma.com/article/who-declares-bundibugyo-ebola-outbreak-a-global-health-emergency-fb7136 2026-05-16 weekly 0.8 https://blogpharma.com/article/fda-leadership-transition-amid-biogen-alzheimers-study-release-aebb50 2026-05-16 weekly 0.8 https://blogpharma.com/article/root-infections-linked-to-systemic-inflammation-and-glucose-dysregulation-e4fca5 2026-05-16 weekly 0.8 https://blogpharma.com/article/fda-drug-division-chief-h-eg-anticipated-to-depart-11917a 2026-05-15 weekly 0.8 https://blogpharma.com/article/study-links-rage-receptor-to-age-related-breast-cancer-severity-7bd373 2026-05-15 weekly 0.8 https://blogpharma.com/article/northwestern-study-maps-als-progression-through-immune-cell-infiltration-e27672 2026-05-15 weekly 0.8 https://blogpharma.com/article/patent-cliffs-drive-m-a-activity-despite-shortage-of-megadeals-77c33a 2026-05-15 weekly 0.8 https://blogpharma.com/article/takeda-to-pay-13-6m-over-alleged-doctor-kickback-scheme-d06857 2026-05-15 weekly 0.8 https://blogpharma.com/article/amgen-tightens-340b-compliance-requirements-for-pharmacy-partners-1419c0 2026-05-15 weekly 0.8 https://blogpharma.com/article/gene-and-rna-therapy-sector-shows-strong-recovery-momentum-in-q1-05e321 2026-05-15 weekly 0.8 https://blogpharma.com/article/patient-recruitment-and-retention-emerge-as-critical-trial-risk-factors-d34223 2026-05-15 weekly 0.8 https://blogpharma.com/article/uk-and-ireland-clinical-trials-landscape-facing-evolving-regulatory-pressures-29f638 2026-05-15 weekly 0.8 https://blogpharma.com/article/oral-glp-1-comparison-data-favors-novo-nordisks-wegovy-formulation-b2288b 2026-05-15 weekly 0.8 https://blogpharma.com/article/aardvarks-prader-willi-program-stalled-by-fda-safety-review-5156c2 2026-05-15 weekly 0.8 https://blogpharma.com/article/regenxbio-pursues-expedited-pathway-for-duchenne-muscle-disease-gene-therapy-e251c7 2026-05-15 weekly 0.8 https://blogpharma.com/article/high-court-upholds-mail-delivery-for-mifepristone-amid-ongoing-litigation-2e325f 2026-05-15 weekly 0.8 https://blogpharma.com/article/leadership-moves-basking-biosciences-appoints-new-chief-medical-officer-c5c6af 2026-05-15 weekly 0.8 https://blogpharma.com/article/industry-mobilizes-support-for-pazdur-as-fda-commissioner-nominee-8bc859 2026-05-15 weekly 0.8 https://blogpharma.com/article/candel-strengthens-prostate-cancer-filing-with-extended-follow-up-data-8bcc70 2026-05-15 weekly 0.8 https://blogpharma.com/article/nonprofit-coalition-launches-trading-platform-for-abandoned-gene-therapies-b70587 2026-05-15 weekly 0.8 https://blogpharma.com/article/cell-therapy-nonprofits-launch-exchange-for-abandoned-programs-545df4 2026-05-15 weekly 0.8 https://blogpharma.com/article/makary-steps-down-as-fda-commissioner-after-turbulent-tenure-6fa217 2026-05-15 weekly 0.8 https://blogpharma.com/article/aardvark-charts-path-forward-after-fda-clinical-hold-a38903 2026-05-15 weekly 0.8 https://blogpharma.com/article/uk-political-shift-threatens-to-reshape-european-drug-pricing-models-f0457a 2026-05-15 weekly 0.8 https://blogpharma.com/article/trump-administration-pushes-germany-to-raise-drug-prices-204d9d 2026-05-15 weekly 0.8 https://blogpharma.com/article/gene-therapy-researcher-unveils-cns-delivery-advances-for-huntingtons-4f9051 2026-05-15 weekly 0.8 https://blogpharma.com/article/ai-driven-cas12l-variant-emerges-as-compact-gene-editing-alternative-e367fc 2026-05-15 weekly 0.8 https://blogpharma.com/article/indian-pharma-eyes-global-expansion-as-innovation-gap-widens-bf826c 2026-05-15 weekly 0.8 https://blogpharma.com/article/gene-therapy-safety-question-emerges-from-rare-brain-tumor-case-d27d5c 2026-05-15 weekly 0.8 https://blogpharma.com/article/mid-tier-pharma-joins-m-a-rush-as-deal-activity-surges-c6a814 2026-05-15 weekly 0.8 https://blogpharma.com/article/tirzepatide-advances-as-potential-type-1-diabetes-therapy-fd4189 2026-05-15 weekly 0.8 https://blogpharma.com/article/stanford-flags-safety-concerns-for-older-adults-using-cannabis-ac63e5 2026-05-15 weekly 0.8 https://blogpharma.com/article/kyvernas-car-t-therapy-approaching-regulatory-milestone-for-rare-neurological-di-22a2f2 2026-05-15 weekly 0.8 https://blogpharma.com/article/serotonin-pathway-linked-to-tinnitus-severity-in-preclinical-research-8e3884 2026-05-15 weekly 0.8 https://blogpharma.com/article/ac-immune-ceo-andrea-pfeifer-to-step-down-after-23-years-b3c185 2026-05-15 weekly 0.8 https://blogpharma.com/article/tempus-ai-expands-bms-partnership-for-trial-optimization-f3a164 2026-05-15 weekly 0.8 https://blogpharma.com/article/nonprofits-launch-digital-platform-for-stalled-gene-therapy-assets-45e367 2026-05-15 weekly 0.8 https://blogpharma.com/article/arna-pharma-and-slate-run-launch-joint-venture-ccc6fa 2026-05-15 weekly 0.8 https://blogpharma.com/article/industry-voices-rally-behind-pazdur-for-fda-leadership-880f37 2026-05-15 weekly 0.8 https://blogpharma.com/article/industry-backs-pazdur-as-potential-fda-leadership-choice-e2128c 2026-05-15 weekly 0.8 https://blogpharma.com/article/biogen-continues-tau-therapy-program-after-mixed-phase-ii-data-e7f999 2026-05-15 weekly 0.8 https://blogpharma.com/article/late-stage-psoriatic-arthritis-programs-advance-ahead-of-eular-182586 2026-05-15 weekly 0.8 https://blogpharma.com/article/florida-researchers-swap-rna-for-dna-in-novel-crispr-architecture-0f593a 2026-05-15 weekly 0.8 https://blogpharma.com/article/massive-bio-partners-with-just-worldwide-to-broaden-oncology-trial-enrollment-0e85bb 2026-05-15 weekly 0.8 https://blogpharma.com/article/kyowa-kirin-gains-fda-clearance-for-revised-crysvita-dosing-regimen-0a17a4 2026-05-15 weekly 0.8 https://blogpharma.com/article/lillys-tirzepatide-shows-durable-weight-loss-in-long-term-study-99d6c9 2026-05-15 weekly 0.8 https://blogpharma.com/article/trump-administration-leverages-trade-pressure-on-german-drug-pricing-62ce93 2026-05-15 weekly 0.8 https://blogpharma.com/article/supply-chain-consistency-emerging-as-critical-cell-therapy-bottleneck-d3ec5c 2026-05-15 weekly 0.8 https://blogpharma.com/article/supreme-court-upholds-mailing-rights-for-mifepristone-1752e1 2026-05-15 weekly 0.8 https://blogpharma.com/article/dna-artifacts-undermine-reliability-of-rna-binding-assays-4d5cf6 2026-05-15 weekly 0.8 https://blogpharma.com/article/dna-guided-cas12-opens-new-crispr-applications-targeting-rna-0c10df 2026-05-15 weekly 0.8 https://blogpharma.com/article/crispr-cas12-system-achieves-rna-targeting-using-dna-guides-d95e43 2026-05-15 weekly 0.8 https://blogpharma.com/article/harvard-team-designs-bacteria-laden-implants-that-fight-infections-autonomously-6e6ce6 2026-05-14 weekly 0.8 https://blogpharma.com/article/encodeds-gene-therapy-shows-strong-seizure-reduction-in-dravet-cases-19526a 2026-05-14 weekly 0.8 https://blogpharma.com/article/ucsf-researchers-engineer-drug-anchors-to-extend-tumor-therapy-duration-270bc0 2026-05-14 weekly 0.8 https://blogpharma.com/article/in-vivo-car-t-momentum-builds-despite-preclinical-limitations-6e5812 2026-05-14 weekly 0.8 https://blogpharma.com/article/cdc-moving-over-160-macaques-to-texas-sanctuary-in-testing-phase-out-76e3ac 2026-05-14 weekly 0.8 https://blogpharma.com/article/global-nicotine-pouch-market-growth-prompts-who-youth-protection-alert-faca1a 2026-05-14 weekly 0.8 https://blogpharma.com/article/search-underway-for-next-fda-commissioner-as-makary-steps-down-af6adb 2026-05-14 weekly 0.8 https://blogpharma.com/article/create-medicines-secures-122m-for-rna-engineered-car-t-platform-cbac61 2026-05-14 weekly 0.8 https://blogpharma.com/article/pharma-faces-stringent-compliance-path-for-tariff-relief-aa579f 2026-05-14 weekly 0.8 https://blogpharma.com/article/orforglipron-demonstrates-weight-loss-maintenance-in-phase-iii-trial-53fd75 2026-05-14 weekly 0.8 https://blogpharma.com/article/uk-pushes-to-streamline-clinical-trial-launches-within-five-months-c8c4c4 2026-05-14 weekly 0.8 https://blogpharma.com/article/survodutide-shows-promise-for-diabetic-kidney-disease-in-preclinical-study-c3d6be 2026-05-14 weekly 0.8 https://blogpharma.com/article/biogen-advances-tau-program-despite-mixed-phase-2-outcomes-25a867 2026-05-14 weekly 0.8 https://blogpharma.com/article/degron-therapeutics-secures-40m-in-series-a-extension-funding-c23dac 2026-05-14 weekly 0.8 https://blogpharma.com/article/astrazenecas-imfinzi-padcev-combo-meets-bladder-cancer-phase-3-goal-6f9a15 2026-05-14 weekly 0.8 https://blogpharma.com/article/uk-health-secretary-streeting-steps-down-after-labour-election-setback-4489f5 2026-05-14 weekly 0.8 https://blogpharma.com/article/uk-health-secretary-steps-down-following-electoral-setback-9154eb 2026-05-14 weekly 0.8 https://blogpharma.com/article/beone-secures-fda-approval-in-competitive-lymphoma-marketplace-5cb17a 2026-05-14 weekly 0.8 https://blogpharma.com/article/macrogenics-divests-manufacturing-unit-to-bora-pharmaceuticals-03efd5 2026-05-14 weekly 0.8 https://blogpharma.com/article/major-digital-health-firms-notably-absent-from-medicare-chronic-care-initiative-6684fe 2026-05-14 weekly 0.8 https://blogpharma.com/article/shionogi-faces-uncertain-path-for-fragile-x-candidate-after-trial-setbacks-084254 2026-05-14 weekly 0.8 https://blogpharma.com/article/biogens-tau-targeting-alzheimers-drug-shows-cognitive-benefit-cb1581 2026-05-14 weekly 0.8 https://blogpharma.com/article/who-praises-tenerife-response-to-hantavirus-outbreak-among-cruise-passengers-faf4b5 2026-05-14 weekly 0.8 https://blogpharma.com/article/regenxbio-pursues-fda-clearance-for-duchenne-gene-therapy-despite-safety-signals-7dadef 2026-05-14 weekly 0.8 https://blogpharma.com/article/penn-medicine-receives-grant-to-integrate-ai-into-medical-education-8fab80 2026-05-14 weekly 0.8 https://blogpharma.com/article/biogens-tau-drug-falls-short-on-primary-endpoint-but-advances-53b2c4 2026-05-14 weekly 0.8 https://blogpharma.com/article/fda-greenlights-multiple-oncology-candidates-in-may-approval-wave-e24ca8 2026-05-14 weekly 0.8 https://blogpharma.com/article/astrazenecas-imfinzi-gains-nhs-approval-for-gastric-cancer-973c0f 2026-05-14 weekly 0.8 https://blogpharma.com/article/gut-hormone-profiles-diverge-in-obese-type-1-diabetes-patients-f5c181 2026-05-14 weekly 0.8 https://blogpharma.com/article/regenxbio-advances-duchenne-gene-therapy-toward-2027-fda-submission-628862 2026-05-14 weekly 0.8 https://blogpharma.com/article/zydus-acquires-assertio-in-166m-strategic-expansion-5cc470 2026-05-14 weekly 0.8 https://blogpharma.com/article/beone-advances-bcl2-inhibitor-as-venclexta-alternative-in-blood-cancer-6960f9 2026-05-14 weekly 0.8 https://blogpharma.com/article/diamantas-takes-fda-helm-after-makary-exit-industry-eyes-steady-hand-01a0c0 2026-05-14 weekly 0.8 https://blogpharma.com/article/coya-therapeutics-gains-fda-fast-track-for-als-combination-therapy-9e2082 2026-05-14 weekly 0.8 https://blogpharma.com/article/eir-partners-takes-majority-stake-in-quartzbios-trial-intelligence-venture-de3006 2026-05-14 weekly 0.8 https://blogpharma.com/article/tunisia-achieves-who-trachoma-elimination-milestone-3b0da5 2026-05-14 weekly 0.8 https://blogpharma.com/article/osel-advances-lactin-v-program-with-phase-iib-pregnancy-trial-cc80a7 2026-05-14 weekly 0.8 https://blogpharma.com/article/pfizer-wins-european-clearance-to-expand-hympavzi-in-inhibitor-positive-hemophil-c3d5d5 2026-05-14 weekly 0.8 https://blogpharma.com/article/global-clinical-trial-reforms-intensify-as-nations-compete-for-sponsor-activity-f3a5ec 2026-05-14 weekly 0.8 https://blogpharma.com/article/nephrology-trials-pivot-toward-precision-medicine-away-from-sprawling-ckd-studie-750c56 2026-05-14 weekly 0.8 https://blogpharma.com/article/nephrology-pivots-to-precision-medicine-in-ckd-drug-development-ea78ae 2026-05-14 weekly 0.8 https://blogpharma.com/article/uc-davis-develops-non-hallucinogenic-psychedelic-compounds-for-depression-82487e 2026-05-14 weekly 0.8 https://blogpharma.com/article/johns-hopkins-team-maps-receptor-transport-pathway-in-neuronal-cells-d4f0a9 2026-05-13 weekly 0.8 https://blogpharma.com/article/bms-and-hengrui-pharma-launch-15-2b-joint-development-partnership-33e973 2026-05-13 weekly 0.8 https://blogpharma.com/article/asgct-chief-focuses-on-rare-disease-access-as-presidency-concludes-cdc2f4 2026-05-13 weekly 0.8 https://blogpharma.com/article/engineered-e-coli-boosts-gadusol-production-for-sustainable-sunscreen-6b8dd4 2026-05-13 weekly 0.8 https://blogpharma.com/article/gene-therapy-startup-faces-reproducibility-challenge-after-initial-success-c52459 2026-05-13 weekly 0.8 https://blogpharma.com/article/upenn-researchers-deploy-ai-to-accelerate-antimicrobial-drug-design-610445 2026-05-13 weekly 0.8 https://blogpharma.com/article/takeda-plans-workforce-reduction-of-4-500-positions-under-new-leadership-1114f4 2026-05-13 weekly 0.8 https://blogpharma.com/article/valneva-trims-workforce-as-travel-vaccine-demand-weakens-4331b9 2026-05-13 weekly 0.8 https://blogpharma.com/article/trump-administration-launches-search-for-new-fda-commissioner-6a3eab 2026-05-13 weekly 0.8 https://blogpharma.com/article/oligonucleotide-discovery-needs-more-than-ai-algorithms-560e12 2026-05-13 weekly 0.8 https://blogpharma.com/article/cellares-partners-with-protgen-to-automate-cell-therapy-manufacturing-929c64 2026-05-13 weekly 0.8 https://blogpharma.com/article/fda-faces-leadership-vacuum-as-top-officials-depart-41d897 2026-05-13 weekly 0.8 https://blogpharma.com/article/novel-chemistry-approaches-address-adc-production-challenges-449159 2026-05-13 weekly 0.8 https://blogpharma.com/article/optimizing-yeast-cell-free-systems-could-lower-protein-manufacturing-costs-791fef 2026-05-13 weekly 0.8 https://blogpharma.com/article/worker-safety-becomes-central-to-adc-manufacturing-strategy-c56906 2026-05-13 weekly 0.8 https://blogpharma.com/article/sartorius-advances-scalable-manufacturing-of-stem-cell-vesicles-5ac1e9 2026-05-13 weekly 0.8 https://blogpharma.com/article/abeona-shifts-strategy-away-from-ophthalmology-gene-therapy-0be0b2 2026-05-13 weekly 0.8 https://blogpharma.com/article/lilly-explores-dose-reduction-strategies-for-sustained-weight-loss-80fc27 2026-05-13 weekly 0.8 https://blogpharma.com/article/gene-therapy-pioneer-tempers-expectations-on-landmark-infant-case-5e7e8e 2026-05-13 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-departs-following-trump-administration-shift-c48534 2026-05-13 weekly 0.8 https://blogpharma.com/article/moderate-coffee-consumption-tied-to-significant-dementia-risk-reduction-cdc7a1 2026-05-13 weekly 0.8 https://blogpharma.com/article/assertio-fields-improved-takeover-offer-ai-biotech-secures-major-funding-4cb510 2026-05-13 weekly 0.8 https://blogpharma.com/article/sickle-cell-patient-victoria-gray-advocates-at-asgct-conference-c2962f 2026-05-13 weekly 0.8 https://blogpharma.com/article/pesticide-exposure-linked-to-rising-early-onset-colorectal-cancer-9aacd0 2026-05-13 weekly 0.8 https://blogpharma.com/article/novo-nordisks-cagrisema-shows-body-composition-gains-in-obesity-trial-d0fdb2 2026-05-13 weekly 0.8 https://blogpharma.com/article/patient-advocacy-groups-push-personalized-prevention-as-european-health-priority-6d4556 2026-05-13 weekly 0.8 https://blogpharma.com/article/gene-therapy-vectors-under-scrutiny-following-pediatric-tumor-case-abf3eb 2026-05-13 weekly 0.8 https://blogpharma.com/article/galapagos-pivots-strategic-direction-with-lakefront-biotherapeutics-rebrand-33f2f7 2026-05-13 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-steps-down-lilly-weight-loss-pill-data-released-8eaca2 2026-05-13 weekly 0.8 https://blogpharma.com/article/who-warns-of-stalled-progress-on-key-global-health-milestones-734659 2026-05-13 weekly 0.8 https://blogpharma.com/article/ai-biotech-funding-shifts-from-hype-to-hard-metrics-c4b852 2026-05-13 weekly 0.8 https://blogpharma.com/article/tesseras-in-vivo-gene-editing-shows-promise-against-sickle-cell-00cb4a 2026-05-13 weekly 0.8 https://blogpharma.com/article/community-oncologys-growing-importance-in-u-s-cancer-treatment-ee3210 2026-05-13 weekly 0.8 https://blogpharma.com/article/geopolitical-tensions-drive-inventory-buildup-for-merck-kgaa-058cc5 2026-05-13 weekly 0.8 https://blogpharma.com/article/novo-nordisk-reports-strong-weight-loss-results-for-high-dose-wegovy-391005 2026-05-13 weekly 0.8 https://blogpharma.com/article/european-union-moves-forward-with-critical-medicines-self-sufficiency-plan-aa33c0 2026-05-13 weekly 0.8 https://blogpharma.com/article/enterprises-inhaled-enac-inhibitor-achieves-phase-ii-success-in-cystic-fibrosis-76e5f5 2026-05-13 weekly 0.8 https://blogpharma.com/article/astrazeneca-gains-uae-clearance-for-novel-hypertension-treatment-2ef9c9 2026-05-13 weekly 0.8 https://blogpharma.com/article/gene-therapy-etx101-shows-promise-in-dravet-syndrome-seizure-management-5a5b26 2026-05-13 weekly 0.8 https://blogpharma.com/article/rfk-jr-s-deprescribing-campaign-raises-safety-concerns-among-clinicians-1c821b 2026-05-13 weekly 0.8 https://blogpharma.com/article/alkermes-sees-positive-phase-iii-results-for-narcolepsy-therapy-lumryz-649cab 2026-05-13 weekly 0.8 https://blogpharma.com/article/isomorphic-labs-lands-2-1b-to-scale-ai-driven-drug-discovery-6efc5f 2026-05-13 weekly 0.8 https://blogpharma.com/article/til-therapies-reshape-oncology-landscape-two-years-post-approval-8b50a5 2026-05-13 weekly 0.8 https://blogpharma.com/article/10x-genomics-sues-element-biosciences-over-multiomics-patent-infringement-76cbac 2026-05-13 weekly 0.8 https://blogpharma.com/article/researchers-decode-biosynthesis-pathway-for-rare-anticancer-plant-alkaloid-161d29 2026-05-13 weekly 0.8 https://blogpharma.com/article/senescent-cell-targeting-offers-new-angle-on-cancer-therapy-2fda07 2026-05-13 weekly 0.8 https://blogpharma.com/article/machine-learning-advances-enable-broader-tcr-specificity-mapping-42aca2 2026-05-13 weekly 0.8 https://blogpharma.com/article/mrna-therapy-reshapes-tumor-immunity-across-multiple-cancer-types-51b36d 2026-05-13 weekly 0.8 https://blogpharma.com/article/lilly-explores-lower-dose-obesity-treatments-for-long-term-weight-management-5a17b1 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-steps-down-after-tumultuous-tenure-4b96a8 2026-05-12 weekly 0.8 https://blogpharma.com/article/usp-launches-three-part-aav-webinar-series-on-manufacturing-analytics-2c3b4d 2026-05-12 weekly 0.8 https://blogpharma.com/article/comprehensive-brain-histamine-atlas-may-guide-psychiatric-drug-development-2a9177 2026-05-12 weekly 0.8 https://blogpharma.com/article/crispr-modified-stem-cells-show-promise-in-aml-relapse-prevention-a188af 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-steps-down-diamantas-assumes-interim-role-d831cd 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-leadership-transition-as-makary-steps-down-b8fc0f 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-steps-down-after-contentious-term-0ea404 2026-05-12 weekly 0.8 https://blogpharma.com/article/eu-targets-domestic-medicine-production-in-supply-security-push-6ac9a7 2026-05-12 weekly 0.8 https://blogpharma.com/article/european-parliament-approves-critical-medicines-supply-chain-regulation-33fdda 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-steps-down-after-year-long-tenure-636bb6 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makary-exits-post-after-weeks-of-uncertainty-bb2216 2026-05-12 weekly 0.8 https://blogpharma.com/article/geopolitical-tensions-drive-cost-pressures-across-pharma-supply-chain-b53f78 2026-05-12 weekly 0.8 https://blogpharma.com/article/journalism-fellowship-reveals-healthcare-ai-coverage-challenges-b75b5a 2026-05-12 weekly 0.8 https://blogpharma.com/article/hims-faces-margin-pressure-amid-intensifying-telehealth-market-competition-cf9e98 2026-05-12 weekly 0.8 https://blogpharma.com/article/rigel-acquires-commercialization-rights-to-arvinas-pfizer-breast-cancer-asset-6facf0 2026-05-12 weekly 0.8 https://blogpharma.com/article/isomorphic-labs-lands-2-1b-raising-stakes-for-ai-drug-discovery-bb4ff6 2026-05-12 weekly 0.8 https://blogpharma.com/article/pharma-pivots-from-ai-hype-to-real-world-deployment-9fdc03 2026-05-12 weekly 0.8 https://blogpharma.com/article/pfizer-arvinas-divest-breast-cancer-asset-to-rigel-92025f 2026-05-12 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-partners-with-hengrui-in-15-2b-drug-development-deal-4b909f 2026-05-12 weekly 0.8 https://blogpharma.com/article/bayer-signals-renewed-appetite-for-pharma-dealmaking-after-years-away-ea8987 2026-05-12 weekly 0.8 https://blogpharma.com/article/alkermes-narcolepsy-drug-meets-phase-3-primary-endpoint-5bc97e 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-technical-team-maintains-focus-amid-leadership-transitions-76f57d 2026-05-12 weekly 0.8 https://blogpharma.com/article/trumprx-member-companies-boost-lobbying-spend-as-program-takes-shape-5e0e98 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-establishes-formal-food-chemical-safety-review-process-targets-bht-and-ada-e0cf53 2026-05-12 weekly 0.8 https://blogpharma.com/article/uc-berkeley-spinout-knit-health-lands-11-6m-for-clinical-ai-8387e8 2026-05-12 weekly 0.8 https://blogpharma.com/article/biotech-workforce-reductions-create-hidden-operational-and-strategic-risks-5c5cbf 2026-05-12 weekly 0.8 https://blogpharma.com/article/who-flags-hantavirus-cases-as-broader-antiviral-pipeline-gaps-emerge-97d905 2026-05-12 weekly 0.8 https://blogpharma.com/article/bristol-myers-hengrui-ink-15-2b-development-and-commercialization-pact-0292b1 2026-05-12 weekly 0.8 https://blogpharma.com/article/capsida-stalled-in-gene-therapy-death-investigation-without-autopsy-data-a44687 2026-05-12 weekly 0.8 https://blogpharma.com/article/mcgill-researchers-identify-glycerol-tnap-pathway-in-brown-fat-thermogenesis-53e520 2026-05-12 weekly 0.8 https://blogpharma.com/article/pain-drug-pipeline-gains-momentum-as-ion-channel-research-attracts-investment-f2a09a 2026-05-12 weekly 0.8 https://blogpharma.com/article/fda-considers-fast-track-route-for-off-label-drug-applications-c4a930 2026-05-12 weekly 0.8 https://blogpharma.com/article/contract-manufacturers-capitalize-on-pharmas-production-asset-sales-738949 2026-05-12 weekly 0.8 https://blogpharma.com/article/bridgebios-experimental-attr-cm-therapy-shows-promise-against-pfizer-standard-e909f6 2026-05-12 weekly 0.8 https://blogpharma.com/article/bridgebios-acoramidis-shows-promise-against-pfizers-attr-rival-a4ec6f 2026-05-12 weekly 0.8 https://blogpharma.com/article/msd-erasca-join-forces-on-ras-mutation-oncology-study-c60706 2026-05-12 weekly 0.8 https://blogpharma.com/article/serif-claims-breakthrough-in-non-viral-gene-delivery-using-primate-model-5f8726 2026-05-12 weekly 0.8 https://blogpharma.com/article/colorectal-cancer-drives-shift-away-from-single-biomarker-reliance-1ceb5a 2026-05-12 weekly 0.8 https://blogpharma.com/article/gsk-taps-chinese-partner-to-accelerate-hepatitis-b-drug-entry-cf754d 2026-05-12 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-partners-with-hengrui-on-13-drug-portfolio-deal-d8660e 2026-05-12 weekly 0.8 https://blogpharma.com/article/inhibrx-reports-encouraging-interim-data-for-inbrx-106-in-head-and-neck-cancer-c4d814 2026-05-12 weekly 0.8 https://blogpharma.com/article/partner-therapeutics-gains-fda-clearance-for-nrg1-fusion-cholangiocarcinoma-drug-d6cbe5 2026-05-12 weekly 0.8 https://blogpharma.com/article/cryopreservation-emerges-as-key-enabler-for-cell-therapy-manufacturing-7106ff 2026-05-12 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-taps-hengrui-for-major-multi-drug-licensing-alliance-e5f385 2026-05-12 weekly 0.8 https://blogpharma.com/article/vivebiotech-expands-lvv-manufacturing-with-stable-producer-cell-platform-ad21de 2026-05-12 weekly 0.8 https://blogpharma.com/article/duke-researchers-identify-ascites-as-barrier-to-ovarian-cancer-cell-death-e69314 2026-05-12 weekly 0.8 https://blogpharma.com/article/optum-rx-launches-fee-based-model-aimed-at-supply-chain-clarity-122f76 2026-05-11 weekly 0.8 https://blogpharma.com/article/colombian-court-validates-compulsory-license-strategy-for-hiv-drug-43b347 2026-05-11 weekly 0.8 https://blogpharma.com/article/study-maps-hiv-escape-routes-from-broadly-neutralizing-antibodies-59279c 2026-05-11 weekly 0.8 https://blogpharma.com/article/azentas-genewiz-unveils-redesigned-gene-synthesis-platform-3c0574 2026-05-11 weekly 0.8 https://blogpharma.com/article/rezdiffra-outperforms-market-projections-as-mash-competition-intensifies-a724aa 2026-05-11 weekly 0.8 https://blogpharma.com/article/cellular-intelligence-acquires-novo-nordisks-parkinsons-cell-therapy-assets-e3efce 2026-05-11 weekly 0.8 https://blogpharma.com/article/fractyl-advances-novel-aav-based-glp-1-gene-therapy-to-human-testing-c139ba 2026-05-11 weekly 0.8 https://blogpharma.com/article/gsk-partners-with-sino-biopharma-to-expand-hepatitis-b-presence-f38c5e 2026-05-11 weekly 0.8 https://blogpharma.com/article/whiteswell-advances-heart-failure-device-despite-safety-setback-e9b035 2026-05-11 weekly 0.8 https://blogpharma.com/article/daiichi-targets-major-revenue-boost-through-adc-oncology-expansion-3468fd 2026-05-11 weekly 0.8 https://blogpharma.com/article/dutch-cruise-ship-reports-ten-suspected-hantavirus-cases-4dcaff 2026-05-11 weekly 0.8 https://blogpharma.com/article/novo-nordisk-divests-parkinsons-cell-therapy-gsk-expands-china-footprint-d540ba 2026-05-11 weekly 0.8 https://blogpharma.com/article/ai-model-maps-gene-regulatory-networks-governing-cell-fate-transitions-64e877 2026-05-11 weekly 0.8 https://blogpharma.com/article/inhibrx-combo-tops-keytruda-monotherapy-in-head-and-neck-cancer-1ffd58 2026-05-11 weekly 0.8 https://blogpharma.com/article/astellas-advances-gene-therapy-for-rare-disease-indication-f757ab 2026-05-11 weekly 0.8 https://blogpharma.com/article/inhibrx-immunotherapy-data-bolsters-keytruda-combination-appeal-67b037 2026-05-11 weekly 0.8 https://blogpharma.com/article/fda-seeks-stakeholder-input-on-drug-repurposing-initiative-4d424b 2026-05-11 weekly 0.8 https://blogpharma.com/article/hengrui-licensed-cardiac-therapy-advances-in-mid-stage-development-e90cd6 2026-05-11 weekly 0.8 https://blogpharma.com/article/biotech-job-cuts-show-signs-of-stabilizing-after-wave-ee461b 2026-05-11 weekly 0.8 https://blogpharma.com/article/medicare-spending-forecast-for-alzheimers-drugs-plummets-sharply-42dc05 2026-05-11 weekly 0.8 https://blogpharma.com/article/csl-moves-to-streamline-operations-across-diverse-biotech-portfolio-6a5db2 2026-05-11 weekly 0.8 https://blogpharma.com/article/fractyl-gains-european-green-light-for-glp-1-gene-therapy-study-ebda21 2026-05-11 weekly 0.8 https://blogpharma.com/article/csl-stock-plummets-as-guidance-cut-major-asset-impairment-announced-391128 2026-05-11 weekly 0.8 https://blogpharma.com/article/fda-establishes-post-approval-framework-for-pregnancy-safety-monitoring-8622f7 2026-05-11 weekly 0.8 https://blogpharma.com/article/fda-establishes-framework-for-gathering-pregnancy-safety-data-post-launch-e492c3 2026-05-11 weekly 0.8 https://blogpharma.com/article/actio-launches-mid-stage-study-of-kcnt1-targeted-epilepsy-therapy-e1452b 2026-05-11 weekly 0.8 https://blogpharma.com/article/acrobiosystems-enhances-hek293-licensing-framework-for-drug-development-aba17c 2026-05-11 weekly 0.8 https://blogpharma.com/article/cell-and-gene-therapy-logistics-emerge-as-critical-competitive-advantage-406aa0 2026-05-11 weekly 0.8 https://blogpharma.com/article/geography-emerges-as-critical-bottleneck-in-cell-and-gene-therapy-scale-up-e42d9a 2026-05-11 weekly 0.8 https://blogpharma.com/article/day-one-completes-enrollment-in-phase-iii-firefly-2-pediatric-glioma-study-326c80 2026-05-11 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-wins-european-clearance-for-sotyktu-in-psoriatic-arthritis-4e2778 2026-05-11 weekly 0.8 https://blogpharma.com/article/medicares-alzheimers-drug-spending-forecast-drops-sharply-67ff7c 2026-05-11 weekly 0.8 https://blogpharma.com/article/astellas-restarts-gene-therapy-trials-for-myotubular-myopathy-b0f01e 2026-05-11 weekly 0.8 https://blogpharma.com/article/engene-stock-plummets-on-weakening-bladder-cancer-trial-data-316124 2026-05-11 weekly 0.8 https://blogpharma.com/article/circular-rna-vaccines-promise-versus-proven-clinical-reality-094dea 2026-05-11 weekly 0.8 https://blogpharma.com/article/metformins-glucose-control-may-work-through-gut-not-liver-b4aa20 2026-05-10 weekly 0.8 https://blogpharma.com/article/licorice-derived-compound-demonstrates-ibd-potential-in-tissue-models-76b362 2026-05-10 weekly 0.8 https://blogpharma.com/article/who-chief-addresses-tenerife-over-hantavirus-fears-d5a823 2026-05-09 weekly 0.8 https://blogpharma.com/article/emerging-biotech-models-startup-dynamics-reshape-industry-landscape-e27e25 2026-05-09 weekly 0.8 https://blogpharma.com/article/hormone-sensitive-lipase-shows-unexpected-role-beyond-fat-mobilization-b90cbc 2026-05-08 weekly 0.8 https://blogpharma.com/article/makarys-fda-exit-signals-shift-in-trumps-health-leadership-3337d2 2026-05-08 weekly 0.8 https://blogpharma.com/article/capricor-sues-nippon-shinyaku-over-duchenne-drug-distribution-dispute-7975fe 2026-05-08 weekly 0.8 https://blogpharma.com/article/fda-approves-seventh-drug-under-priority-voucher-pilot-initiative-493bef 2026-05-08 weekly 0.8 https://blogpharma.com/article/fda-commissioner-makarys-position-reportedly-under-threat-054d26 2026-05-08 weekly 0.8 https://blogpharma.com/article/trump-administration-signals-plan-to-remove-fda-commissioner-makary-2b07c7 2026-05-08 weekly 0.8 https://blogpharma.com/article/daiichi-sankyo-takes-nearly-1b-charge-on-adc-capacity-plans-116282 2026-05-08 weekly 0.8 https://blogpharma.com/article/digital-systems-transform-cell-and-gene-therapy-regulatory-compliance-e8a25f 2026-05-08 weekly 0.8 https://blogpharma.com/article/beacon-gene-therapy-demonstrates-sustained-efficacy-through-one-year-d73fbf 2026-05-08 weekly 0.8 https://blogpharma.com/article/genomics-pioneer-j-craig-venter-dies-at-79-4ef851 2026-05-08 weekly 0.8 https://blogpharma.com/article/japans-drug-price-overhaul-delivers-steeper-2024-reductions-d789dc 2026-05-08 weekly 0.8 https://blogpharma.com/article/gilead-delivers-strong-first-quarter-on-hiv-portfolio-momentum-496243 2026-05-08 weekly 0.8 https://blogpharma.com/article/lilly-commits-additional-4-5b-to-boost-u-s-manufacturing-capacity-a659c1 2026-05-08 weekly 0.8 https://blogpharma.com/article/biogen-eisai-face-fda-delay-on-leqembi-subcutaneous-formulation-15d356 2026-05-08 weekly 0.8 https://blogpharma.com/article/gene-therapy-meeting-returns-to-boston-after-16-year-hiatus-c06023 2026-05-08 weekly 0.8 https://blogpharma.com/article/artificial-intelligence-pushes-laboratory-automation-toward-self-directed-operat-580ed0 2026-05-08 weekly 0.8 https://blogpharma.com/article/immunic-appoints-panzara-as-chief-medical-officer-45dfc0 2026-05-08 weekly 0.8 https://blogpharma.com/article/biotech-industry-embraces-met-gala-fashion-tradition-d2326a 2026-05-08 weekly 0.8 https://blogpharma.com/article/parcelbio-secures-13m-to-advance-durable-mrna-technology-platform-c8cc48 2026-05-08 weekly 0.8 https://blogpharma.com/article/fda-signals-fresh-look-at-pierre-fabre-cell-therapy-after-rejection-0d97c1 2026-05-08 weekly 0.8 https://blogpharma.com/article/regeneron-gains-fda-approval-for-first-otof-gene-therapy-2e2471 2026-05-08 weekly 0.8 https://blogpharma.com/article/capricor-takes-legal-action-against-japanese-partner-over-dmd-therapy-4a9380 2026-05-08 weekly 0.8 https://blogpharma.com/article/fda-clarifies-standards-for-studying-drug-safety-during-pregnancy-6330e2 2026-05-08 weekly 0.8 https://blogpharma.com/article/mergers-and-acquisitions-surge-across-pharma-sector-in-2026-3dafe8 2026-05-08 weekly 0.8 https://blogpharma.com/article/fda-proposes-regulatory-shift-from-gender-to-biological-sex-language-f9c818 2026-05-08 weekly 0.8 https://blogpharma.com/article/asgct-recognizes-abou-el-enein-for-car-t-cell-engineering-advances-bf70c3 2026-05-08 weekly 0.8 https://blogpharma.com/article/elite-ai-researchers-bypassing-pharma-for-academic-tech-careers-07a15d 2026-05-08 weekly 0.8 https://blogpharma.com/article/kailera-nektar-and-hemab-lead-april-biotech-funding-surge-bba2ee 2026-05-08 weekly 0.8 https://blogpharma.com/article/holles-ascends-to-ceo-role-at-adc-biotech-following-third-harmonic-exit-ec16af 2026-05-08 weekly 0.8 https://blogpharma.com/article/capricor-takes-legal-action-against-nippon-shinyaku-over-dmd-therapy-deal-e324ae 2026-05-08 weekly 0.8 https://blogpharma.com/article/constipation-medication-shows-unexpected-kidney-protection-benefit-fa4ed1 2026-05-08 weekly 0.8 https://blogpharma.com/article/novos-oral-wegovy-launch-gains-early-traction-against-lilly-competition-eceb2b 2026-05-08 weekly 0.8 https://blogpharma.com/article/engene-shares-legend-trial-update-on-bladder-cancer-immunotherapy-70bd18 2026-05-08 weekly 0.8 https://blogpharma.com/article/novartis-breaks-ground-on-texas-rlt-manufacturing-hub-1d13b7 2026-05-08 weekly 0.8 https://blogpharma.com/article/entrada-therapeutics-reports-underwhelming-dmd-results-shares-decline-91a1b9 2026-05-08 weekly 0.8 https://blogpharma.com/article/researchers-block-bacterial-communication-to-combat-gum-disease-d73ac2 2026-05-08 weekly 0.8 https://blogpharma.com/article/paradigm-healths-esource-tool-automates-trial-data-transfer-f285eb 2026-05-08 weekly 0.8 https://blogpharma.com/article/paradigm-health-tool-automates-clinical-trial-data-workflows-7dbeca 2026-05-08 weekly 0.8 https://blogpharma.com/article/medsir-releases-data-from-dual-her2-positive-breast-cancer-trials-f0d3f4 2026-05-08 weekly 0.8 https://blogpharma.com/article/angelini-to-acquire-catalyst-pharmaceuticals-in-4-1b-deal-f7bced 2026-05-08 weekly 0.8 https://blogpharma.com/article/tpgs-gains-traction-in-advanced-injectable-formulation-technologies-4fb07d 2026-05-08 weekly 0.8 https://blogpharma.com/article/autoimmune-focused-odyssey-therapeutics-launches-public-trading-after-279m-ipo-008c01 2026-05-08 weekly 0.8 https://blogpharma.com/article/brazilian-tree-compounds-show-multi-target-activity-against-sars-cov-2-4f4990 2026-05-08 weekly 0.8 https://blogpharma.com/article/immune-focused-odyssey-secures-279m-in-comeback-ipo-c5b509 2026-05-08 weekly 0.8 https://blogpharma.com/article/cell-volume-regulation-emerges-as-critical-inflammatory-trigger-in-macrophages-735f80 2026-05-07 weekly 0.8 https://blogpharma.com/article/astellas-advances-stem-cell-therapy-for-macular-degeneration-c65665 2026-05-07 weekly 0.8 https://blogpharma.com/article/accelerating-cancer-immunotherapy-development-industry-leaders-discuss-manufactu-31ee6c 2026-05-07 weekly 0.8 https://blogpharma.com/article/vyriad-debuts-modular-viral-vector-platform-for-car-t-manufacturing-539be8 2026-05-07 weekly 0.8 https://blogpharma.com/article/sarepta-stock-slides-despite-gene-therapy-beat-2d8f38 2026-05-07 weekly 0.8 https://blogpharma.com/article/la-jolla-scientists-map-human-antibodies-for-measles-prevention-and-treatment-ac7279 2026-05-07 weekly 0.8 https://blogpharma.com/article/oral-glp-1s-target-reward-circuits-beyond-appetite-control-370632 2026-05-07 weekly 0.8 https://blogpharma.com/article/digital-pcr-advances-address-multiplexing-and-dynamic-range-hurdles-f25006 2026-05-07 weekly 0.8 https://blogpharma.com/article/cellular-origins-immatics-partner-on-cell-therapy-manufacturing-automation-e863ce 2026-05-07 weekly 0.8 https://blogpharma.com/article/who-mobilizes-response-to-hantavirus-outbreak-on-cruise-ship-b9d08a 2026-05-07 weekly 0.8 https://blogpharma.com/article/amazon-pharmacy-expands-kiosk-offerings-with-ozempic-oral-formulation-2f51e3 2026-05-07 weekly 0.8 https://blogpharma.com/article/gsk-invests-1-billion-in-siranbio-metabolic-disease-technology-97f858 2026-05-07 weekly 0.8 https://blogpharma.com/article/engene-stock-plummets-on-disappointing-bladder-cancer-trial-update-c0265f 2026-05-07 weekly 0.8 https://blogpharma.com/article/insurers-signal-recovery-despite-lingering-cost-pressures-fed105 2026-05-07 weekly 0.8 https://blogpharma.com/article/blackstone-deploys-250m-in-anagram-for-cf-related-disease-program-79da90 2026-05-07 weekly 0.8 https://blogpharma.com/article/angelini-pharmaceuticals-acquires-catalyst-for-4-billion-cns-portfolio-552919 2026-05-07 weekly 0.8 https://blogpharma.com/article/entradas-duchenne-program-stumbles-stock-plummets-on-trial-letdown-59b1a0 2026-05-07 weekly 0.8 https://blogpharma.com/article/entrada-shares-decline-following-duchenne-study-setback-17a49d 2026-05-07 weekly 0.8 https://blogpharma.com/article/roche-bolsters-oncology-ai-capabilities-with-pathai-acquisition-3df2af 2026-05-07 weekly 0.8 https://blogpharma.com/article/fda-independence-under-scrutiny-as-political-pressures-mount-d0f7da 2026-05-07 weekly 0.8 https://blogpharma.com/article/amgen-expands-puerto-rico-investment-novartis-exits-german-plant-67b0bf 2026-05-07 weekly 0.8 https://blogpharma.com/article/sanofi-withdraws-diabetes-drug-from-fda-fast-track-review-078042 2026-05-07 weekly 0.8 https://blogpharma.com/article/autonomous-labs-reshape-drug-discovery-workforce-ginkgo-bioworks-says-77f0b8 2026-05-07 weekly 0.8 https://blogpharma.com/article/autonomous-laboratory-systems-reshape-drug-discovery-workforce-strategy-31ad46 2026-05-07 weekly 0.8 https://blogpharma.com/article/agbt-honors-emerging-agricultural-genomics-scientists-with-2026-awards-bb817b 2026-05-07 weekly 0.8 https://blogpharma.com/article/fda-signals-reconsideration-of-rejected-rare-cancer-drug-7b193a 2026-05-07 weekly 0.8 https://blogpharma.com/article/ataras-rejected-cell-therapy-gets-path-to-fda-reconsideration-3c71c9 2026-05-07 weekly 0.8 https://blogpharma.com/article/new-research-examines-barriers-to-colorectal-cancer-screening-uptake-fc6db0 2026-05-07 weekly 0.8 https://blogpharma.com/article/trispecific-antibodies-emerge-as-industrys-next-therapeutic-frontier-800d8c 2026-05-07 weekly 0.8 https://blogpharma.com/article/pennsylvania-takes-legal-action-against-ai-chatbot-over-doctor-impersonation-50c6b2 2026-05-07 weekly 0.8 https://blogpharma.com/article/fda-reverses-course-on-rare-blood-cancer-therapy-ebvallo-15f724 2026-05-07 weekly 0.8 https://blogpharma.com/article/angelini-acquires-catalyst-pharma-for-4-1-billion-to-expand-rare-neurology-franc-27646b 2026-05-07 weekly 0.8 https://blogpharma.com/article/novel-dual-mechanism-obesity-compound-shows-enhanced-efficacy-in-preclinical-stu-ed773f 2026-05-07 weekly 0.8 https://blogpharma.com/article/eli-lilly-commits-4-5b-to-expand-indiana-manufacturing-hub-12622d 2026-05-07 weekly 0.8 https://blogpharma.com/article/fda-reverses-course-on-modernas-mrna-influenza-candidate-38ff54 2026-05-07 weekly 0.8 https://blogpharma.com/article/taimei-and-c-r-research-partner-on-ai-trial-operations-software-f60d8b 2026-05-07 weekly 0.8 https://blogpharma.com/article/daiichi-sankyo-taps-waiv-for-adc-biomarker-discovery-platform-fa788d 2026-05-07 weekly 0.8 https://blogpharma.com/article/fda-confronts-workforce-crisis-after-sweeping-personnel-cuts-14bdc0 2026-05-07 weekly 0.8 https://blogpharma.com/article/halozyme-licenses-hypercon-platform-to-oruka-for-orka-001-development-fae1ef 2026-05-07 weekly 0.8 https://blogpharma.com/article/alebund-completes-enrollment-for-ap301-hyperphosphatemia-study-3eb417 2026-05-07 weekly 0.8 https://blogpharma.com/article/lab-thread-ceo-discusses-intelligence-tools-reshaping-research-operations-856c60 2026-05-07 weekly 0.8 https://blogpharma.com/article/bayer-expands-eye-care-portfolio-with-perfuse-therapeutics-deal-97037b 2026-05-07 weekly 0.8 https://blogpharma.com/article/astrazenecas-il-33-antibody-advances-in-copd-treatment-182749 2026-05-07 weekly 0.8 https://blogpharma.com/article/cell-therapy-manufacturing-becomes-the-bottleneck-in-drug-development-9ee294 2026-05-06 weekly 0.8 https://blogpharma.com/article/early-risk-assessment-becomes-critical-in-oral-solid-dosage-development-87f716 2026-05-06 weekly 0.8 https://blogpharma.com/article/early-risk-assessment-becomes-critical-in-oral-solid-dose-development-ee2933 2026-05-06 weekly 0.8 https://blogpharma.com/article/scientists-identify-over-1-700-previously-unknown-human-proteins-dfb4db 2026-05-06 weekly 0.8 https://blogpharma.com/article/amgen-abbvie-report-first-quarter-revenue-hit-from-ira-price-talks-ac096e 2026-05-06 weekly 0.8 https://blogpharma.com/article/eli-lilly-announces-4-5b-indiana-manufacturing-expansion-58c5c8 2026-05-06 weekly 0.8 https://blogpharma.com/article/beone-medicines-discontinues-six-programs-amid-pipeline-consolidation-1f92dc 2026-05-06 weekly 0.8 https://blogpharma.com/article/lonza-scales-up-adc-manufacturing-capacity-amid-market-surge-b1a318 2026-05-06 weekly 0.8 https://blogpharma.com/article/fda-deploys-upgraded-ai-system-across-agency-operations-e3cd5c 2026-05-06 weekly 0.8 https://blogpharma.com/article/sanofi-withdraws-diabetes-drug-from-fda-fast-track-program-a6f438 2026-05-06 weekly 0.8 https://blogpharma.com/article/bayer-acquires-perfuse-in-2-45b-eye-care-expansion-174c76 2026-05-06 weekly 0.8 https://blogpharma.com/article/heavy-chain-architecture-emerges-as-key-to-bispecific-antibody-manufacturing-06e9f9 2026-05-06 weekly 0.8 https://blogpharma.com/article/nc-state-spinout-targets-viral-vector-purification-with-peptide-technology-863a43 2026-05-06 weekly 0.8 https://blogpharma.com/article/moss-based-cell-culture-emerges-as-alternative-to-cho-for-complex-proteins-3f6fe2 2026-05-06 weekly 0.8 https://blogpharma.com/article/industry-pushes-regulators-to-recognize-peer-gmp-audits-d6af74 2026-05-06 weekly 0.8 https://blogpharma.com/article/novo-nordisk-raises-forecasts-on-oral-wegovy-momentum-073b5d 2026-05-06 weekly 0.8 https://blogpharma.com/article/urv-researchers-unveil-chemistry-compliant-ai-for-molecular-generation-ba3f1b 2026-05-06 weekly 0.8 https://blogpharma.com/article/madrigals-mash-drug-outperforms-forecasts-in-strong-q1-launch-d480cc 2026-05-06 weekly 0.8 https://blogpharma.com/article/ex-orbital-researchers-found-parcelbio-to-advance-mrna-therapeutics-75ce20 2026-05-06 weekly 0.8 https://blogpharma.com/article/bayer-acquires-perfuse-therapeutics-for-2-45-billion-1314cb 2026-05-06 weekly 0.8 https://blogpharma.com/article/optogenetics-platform-achieves-double-industry-standard-cell-culture-yields-0ee2ce 2026-05-06 weekly 0.8 https://blogpharma.com/article/avalo-advances-dermatology-pipeline-with-phase-2-win-secures-375m-funding-28a39a 2026-05-06 weekly 0.8 https://blogpharma.com/article/world-health-organization-launches-free-clinical-trial-training-platform-3c4e56 2026-05-06 weekly 0.8 https://blogpharma.com/article/avalos-skin-disease-candidate-shows-promise-biontech-restructures-b3ad2a 2026-05-06 weekly 0.8 https://blogpharma.com/article/fda-tests-streamlined-one-day-inspection-model-to-boost-oversight-efficiency-403678 2026-05-06 weekly 0.8 https://blogpharma.com/article/gsk-invests-1b-in-chinese-sirna-firm-for-metabolic-disease-program-3f7354 2026-05-06 weekly 0.8 https://blogpharma.com/article/novo-nordisk-lifts-guidance-on-stronger-wegovy-pill-sales-2283ef 2026-05-06 weekly 0.8 https://blogpharma.com/article/phrma-launches-major-campaign-against-340b-drug-discount-program-558277 2026-05-06 weekly 0.8 https://blogpharma.com/article/aprils-biotech-m-a-boom-dominated-by-targeted-therapies-and-ai-a349cf 2026-05-06 weekly 0.8 https://blogpharma.com/article/citius-oncology-secures-36-5m-to-advance-lymphir-commercialization-387216 2026-05-06 weekly 0.8 https://blogpharma.com/article/novelty-nobility-taps-agc-biologics-for-bispecific-antibody-scale-up-26d7bf 2026-05-06 weekly 0.8 https://blogpharma.com/article/chicago-conference-highlights-new-digestive-disease-treatment-progress-8c6696 2026-05-06 weekly 0.8 https://blogpharma.com/article/digestive-disease-week-2026-highlights-major-trial-advances-0f6cfc 2026-05-06 weekly 0.8 https://blogpharma.com/article/viridian-gains-35-on-positive-phase-iii-ted-trial-results-7dd20c 2026-05-06 weekly 0.8 https://blogpharma.com/article/cellcentric-secures-220m-series-d-for-late-stage-myeloma-candidate-157a34 2026-05-06 weekly 0.8 https://blogpharma.com/article/cellcentric-secures-220m-to-advance-multiple-myeloma-candidate-46fb78 2026-05-06 weekly 0.8 https://blogpharma.com/article/bayer-acquires-perfuse-therapeutics-in-300m-ophthalmology-deal-2ef210 2026-05-06 weekly 0.8 https://blogpharma.com/article/novo-nordisks-oral-obesity-drug-hits-million-patient-milestone-d855c6 2026-05-06 weekly 0.8 https://blogpharma.com/article/oragenics-expands-onp-002-trial-with-second-clinical-site-f5f435 2026-05-06 weekly 0.8 https://blogpharma.com/article/pipeline-race-heats-up-in-sickle-cell-disease-beyond-casgevy-aa681e 2026-05-06 weekly 0.8 https://blogpharma.com/article/nocion-therapeutics-reaches-full-enrollment-in-aspire-phase-iib-study-f1e701 2026-05-06 weekly 0.8 https://blogpharma.com/article/merck-sharp-dohme-finalizes-terns-deal-for-cml-expansion-59ac6c 2026-05-06 weekly 0.8 https://blogpharma.com/article/cdmos-seek-ways-to-minimize-waste-in-aseptic-fill-finish-operations-fdcc37 2026-05-06 weekly 0.8 https://blogpharma.com/article/long-trusted-knee-meniscus-surgery-shows-no-advantage-over-placebo-78846c 2026-05-06 weekly 0.8 https://blogpharma.com/article/ucb-acquires-candid-therapeutics-in-2-2b-immunology-deal-6d929f 2026-05-06 weekly 0.8 https://blogpharma.com/article/researchers-identify-novel-fusarium-resistance-gene-from-wild-grass-species-375dfb 2026-05-05 weekly 0.8 https://blogpharma.com/article/fda-grants-marketing-authorization-for-four-glas-nicotine-devices-d9b12f 2026-05-05 weekly 0.8 https://blogpharma.com/article/brain-entropy-shifts-linked-to-psilocybins-lasting-mental-health-benefits-3e3181 2026-05-05 weekly 0.8 https://blogpharma.com/article/intercept-abandons-next-gen-liver-drug-after-phase-2-disappointment-cc053c 2026-05-05 weekly 0.8 https://blogpharma.com/article/injectable-biomaterial-targets-internal-tissue-repair-via-bloodstream-324af0 2026-05-05 weekly 0.8 https://blogpharma.com/article/pfizer-ceo-rules-out-major-m-a-in-near-term-e9a97d 2026-05-05 weekly 0.8 https://blogpharma.com/article/weight-loss-drug-users-face-unexpected-social-stigma-research-shows-9c4d43 2026-05-05 weekly 0.8 https://blogpharma.com/article/pharma-reputation-edges-up-among-patient-groups-despite-pricing-concerns-f55f95 2026-05-05 weekly 0.8 https://blogpharma.com/article/biontech-announces-major-manufacturing-contraction-1-860-jobs-at-risk-f9cc48 2026-05-05 weekly 0.8 https://blogpharma.com/article/parsley-health-expands-insurance-coverage-across-united-states-7a37bf 2026-05-05 weekly 0.8 https://blogpharma.com/article/viridians-thyroid-eye-disease-candidate-shows-stronger-chronic-disease-efficacy-54e6a4 2026-05-05 weekly 0.8 https://blogpharma.com/article/johnson-johnsons-ottava-robot-clears-pivotal-gastric-bypass-trial-f8367c 2026-05-05 weekly 0.8 https://blogpharma.com/article/gene-therapy-revival-cleveland-biotech-advances-takeda-posts-phase-2-3-success-785112 2026-05-05 weekly 0.8 https://blogpharma.com/article/lillys-omvoh-maintains-ulcerative-colitis-remission-over-four-years-6ffd8b 2026-05-05 weekly 0.8 https://blogpharma.com/article/swiss-pharma-sector-maintains-composure-amid-trade-uncertainty-445065 2026-05-05 weekly 0.8 https://blogpharma.com/article/madrigal-invests-1-billion-in-arrowheads-mash-focused-gene-therapy-985031 2026-05-05 weekly 0.8 https://blogpharma.com/article/pfizer-winds-down-trillium-program-amid-elevated-research-spending-8b5984 2026-05-05 weekly 0.8 https://blogpharma.com/article/analysts-may-be-underweighting-eli-lillys-hepatic-safety-concerns-94cc32 2026-05-05 weekly 0.8 https://blogpharma.com/article/microbiome-biotech-secures-48m-to-develop-immunotherapy-candidates-720f3e 2026-05-05 weekly 0.8 https://blogpharma.com/article/j-j-advances-ibd-combo-to-phase-3-despite-failed-mid-stage-trials-0e1879 2026-05-05 weekly 0.8 https://blogpharma.com/article/madrigal-pursues-broad-mash-portfolio-with-arrowhead-acquisition-be5a28 2026-05-05 weekly 0.8 https://blogpharma.com/article/major-healthcare-systems-develop-in-house-ai-rather-than-buy-startup-tools-d853a0 2026-05-05 weekly 0.8 https://blogpharma.com/article/kennedy-targets-ssri-prescribing-practices-j-j-ibd-therapy-stumbles-8f7be5 2026-05-05 weekly 0.8 https://blogpharma.com/article/vertex-q1-results-disappoint-on-key-product-sales-78262c 2026-05-05 weekly 0.8 https://blogpharma.com/article/cytokinetics-expands-cardiac-market-with-non-obstructive-hcm-data-71c5d2 2026-05-05 weekly 0.8 https://blogpharma.com/article/ncsu-develops-evaluation-tool-for-inclusive-remote-collaboration-software-81b93f 2026-05-05 weekly 0.8 https://blogpharma.com/article/cytokinetics-expands-hcm-opportunity-beyond-bristol-myers-reach-8c8891 2026-05-05 weekly 0.8 https://blogpharma.com/article/non-viral-gene-therapies-gain-traction-as-safer-manufacturing-alternative-5f86bb 2026-05-05 weekly 0.8 https://blogpharma.com/article/ucb-expands-tce-portfolio-with-2-2-billion-candid-therapeutics-deal-75d3bc 2026-05-05 weekly 0.8 https://blogpharma.com/article/mirums-volixibat-meets-primary-endpoint-in-psc-study-61b7d0 2026-05-05 weekly 0.8 https://blogpharma.com/article/fda-clears-langlara-in-first-approval-for-lannett-sunshine-lake-partnership-c7bef5 2026-05-05 weekly 0.8 https://blogpharma.com/article/survey-examines-hospital-it-infrastructure-amid-digital-care-expansion-137bd6 2026-05-05 weekly 0.8 https://blogpharma.com/article/hospital-it-infrastructure-struggles-to-meet-modern-care-demands-d375e2 2026-05-05 weekly 0.8 https://blogpharma.com/article/takedas-experimental-pid-therapy-hits-pivotal-trial-goal-c9152c 2026-05-05 weekly 0.8 https://blogpharma.com/article/gene-therapy-developer-latus-bio-lands-97m-series-a-e134b3 2026-05-05 weekly 0.8 https://blogpharma.com/article/uk-biotech-cytospire-raises-83m-for-gamma-delta-t-cell-platform-7222a4 2026-05-05 weekly 0.8 https://blogpharma.com/article/j-js-ibd-combo-misses-primary-trial-goal-but-advances-forward-f4e8e5 2026-05-05 weekly 0.8 https://blogpharma.com/article/biotech-companies-race-to-restore-thymic-function-for-immune-renewal-a53a7c 2026-05-05 weekly 0.8 https://blogpharma.com/article/novel-single-cell-platform-enables-high-resolution-plant-gene-screening-82e118 2026-05-05 weekly 0.8 https://blogpharma.com/article/new-plant-cell-screening-platform-unlocks-functional-genetics-research-4a4034 2026-05-05 weekly 0.8 https://blogpharma.com/article/vertex-halts-mrna-cystic-fibrosis-program-due-to-safety-concerns-67913b 2026-05-04 weekly 0.8 https://blogpharma.com/article/mit-research-reveals-gene-arrangement-controls-dna-topology-and-expression-df2a3a 2026-05-04 weekly 0.8 https://blogpharma.com/article/stem-cell-mutations-offer-natural-escape-route-in-aplastic-anemia-466da5 2026-05-04 weekly 0.8 https://blogpharma.com/article/protein-biomarkers-emerge-as-risk-mitigation-tool-in-drug-development-cd2a43 2026-05-04 weekly 0.8 https://blogpharma.com/article/new-algorithm-tracks-bacterial-strains-within-complex-microbial-populations-b73b2e 2026-05-04 weekly 0.8 https://blogpharma.com/article/france-penalizes-novo-nordisk-eli-lilly-for-weight-loss-drug-marketing-2fa80b 2026-05-04 weekly 0.8 https://blogpharma.com/article/novel-optical-crispr-screening-identifies-nf-b-pathway-controllers-97e098 2026-05-04 weekly 0.8 https://blogpharma.com/article/fda-narrows-cber-leadership-search-to-final-contenders-f83ab6 2026-05-04 weekly 0.8 https://blogpharma.com/article/celcuity-touts-fresh-data-for-pik3ca-driven-breast-cancer-candidate-1018d5 2026-05-04 weekly 0.8 https://blogpharma.com/article/high-court-clears-path-for-mailed-mifepristone-amid-legal-battle-e9d368 2026-05-04 weekly 0.8 https://blogpharma.com/article/arginine-shows-promise-in-preclinical-alzheimers-disease-models-5be9e5 2026-05-04 weekly 0.8 https://blogpharma.com/article/celcuitys-pik3ca-targeted-drug-advances-in-breast-cancer-e30cd6 2026-05-04 weekly 0.8 https://blogpharma.com/article/elevance-medicare-fraud-litigation-spotlights-discovery-delays-3a60c9 2026-05-04 weekly 0.8 https://blogpharma.com/article/latus-secures-97m-to-develop-novel-huntingtons-gene-therapy-approach-d9b855 2026-05-04 weekly 0.8 https://blogpharma.com/article/lean-teams-and-foreign-assets-reshape-biotech-startup-formation-3409aa 2026-05-04 weekly 0.8 https://blogpharma.com/article/ucb-expands-autoimmune-portfolio-through-candid-antibody-acquisition-22a674 2026-05-04 weekly 0.8 https://blogpharma.com/article/big-tech-giants-race-to-dominate-ai-powered-drug-discovery-9ce556 2026-05-04 weekly 0.8 https://blogpharma.com/article/drugmakers-seek-supreme-court-intervention-on-mifepristone-access-73b1ab 2026-05-04 weekly 0.8 https://blogpharma.com/article/windward-bio-raises-165m-for-phase-3-asthma-program-44ac0e 2026-05-04 weekly 0.8 https://blogpharma.com/article/noninvasive-glucose-monitoring-technologies-reshape-diabetes-management-landscap-0fe8aa 2026-05-04 weekly 0.8 https://blogpharma.com/article/lakewood-amedex-shows-positive-efficacy-signals-for-diabetic-foot-ulcer-therapy-63e5c9 2026-05-04 weekly 0.8 https://blogpharma.com/article/arrowhead-gains-australian-clearance-for-rare-lipid-disorder-drug-d4b6a5 2026-05-04 weekly 0.8 https://blogpharma.com/article/ucb-acquires-candid-for-2-2b-to-expand-bispecific-pipeline-24fb52 2026-05-04 weekly 0.8 https://blogpharma.com/article/data-integration-emerges-as-critical-bottleneck-in-oncology-ai-drug-discovery-6a9018 2026-05-04 weekly 0.8 https://blogpharma.com/article/celcuity-releases-phase-iii-data-for-pik3ca-mutant-breast-cancer-5581b0 2026-05-04 weekly 0.8 https://blogpharma.com/article/novo-nordisk-brings-oral-glp-1-option-to-us-diabetes-market-d352ef 2026-05-04 weekly 0.8 https://blogpharma.com/article/research-uncovers-creatines-broader-health-benefits-beyond-athletic-performance-00fcfd 2026-05-04 weekly 0.8 https://blogpharma.com/article/global-health-leaders-decry-worsening-attacks-on-medical-infrastructure-470c30 2026-05-04 weekly 0.8 https://blogpharma.com/article/glp-1-drugs-show-unexpected-mental-health-benefits-in-large-study-7a8fd3 2026-05-04 weekly 0.8 https://blogpharma.com/article/ucb-invests-2-billion-in-candid-therapeutics-t-cell-platform-593e5e 2026-05-04 weekly 0.8 https://blogpharma.com/article/researchers-develop-digital-lung-models-for-personalized-drug-testing-dd6a26 2026-05-04 weekly 0.8 https://blogpharma.com/article/erasca-stock-plummets-on-clinical-safety-concerns-and-patent-dispute-0d21d2 2026-05-03 weekly 0.8 https://blogpharma.com/article/bristol-myers-faces-critical-year-as-pharma-earnings-season-hits-c4b02d 2026-05-02 weekly 0.8 https://blogpharma.com/article/fda-approves-first-protac-drug-for-advanced-breast-cancer-55591d 2026-05-01 weekly 0.8 https://blogpharma.com/article/t-cell-vesicles-carrying-dna-enhance-tumor-immunity-in-preclinical-models-eea067 2026-05-01 weekly 0.8 https://blogpharma.com/article/ucsd-researchers-link-protein-recycling-dysfunction-to-t-cell-exhaustion-668d30 2026-05-01 weekly 0.8 https://blogpharma.com/article/moderna-negotiates-label-expansion-with-fda-for-covid-vaccine-71b983 2026-05-01 weekly 0.8 https://blogpharma.com/article/fda-greenlights-pfizer-arvinas-breast-cancer-therapy-with-limited-clinical-evide-957365 2026-05-01 weekly 0.8 https://blogpharma.com/article/amgen-advances-maritide-with-switch-study-vs-glp-1-rivals-c53711 2026-05-01 weekly 0.8 https://blogpharma.com/article/cytiva-and-rockwell-launch-manufacturing-control-system-for-biotech-d85270 2026-05-01 weekly 0.8 https://blogpharma.com/article/who-extends-pabs-negotiations-for-pandemic-preparedness-framework-a5005a 2026-05-01 weekly 0.8 https://blogpharma.com/article/seaport-therapeutics-debuts-with-strong-market-reception-cns-focus-9aa066 2026-05-01 weekly 0.8 https://blogpharma.com/article/ailux-names-former-astrazeneca-r-d-executive-as-chief-scientific-officer-c0895a 2026-05-01 weekly 0.8 https://blogpharma.com/article/summits-trial-misstep-raises-questions-over-interim-analysis-strategy-a17a4b 2026-05-01 weekly 0.8 https://blogpharma.com/article/moderna-offsets-domestic-decline-with-strong-international-covid-revenue-a8577e 2026-05-01 weekly 0.8 https://blogpharma.com/article/samsung-biologics-union-initiates-strike-over-compensation-talks-75c1c1 2026-05-01 weekly 0.8 https://blogpharma.com/article/revolution-medicines-gains-fda-nod-for-expanded-access-pancreatic-program-84bcd2 2026-05-01 weekly 0.8 https://blogpharma.com/article/cue-biopharma-restructures-leadership-acquires-asian-allergy-program-4fc6cc 2026-05-01 weekly 0.8 https://blogpharma.com/article/endpoints-news-to-host-exclusive-earnings-analysis-session-cfb526 2026-05-01 weekly 0.8 https://blogpharma.com/article/fda-greenlights-axsomes-alzheimers-agitation-treatment-3194c0 2026-05-01 weekly 0.8 https://blogpharma.com/article/auvelity-gains-fda-approval-as-novel-non-antipsychotic-for-alzheimers-agitation-83223d 2026-05-01 weekly 0.8 https://blogpharma.com/article/mixed-q1-results-biogen-surges-while-bristol-myers-regeneron-face-investor-skept-d22be7 2026-05-01 weekly 0.8 https://blogpharma.com/article/axsome-secures-fda-clearance-for-alzheimers-agitation-treatment-bd5085 2026-05-01 weekly 0.8 https://blogpharma.com/article/fda-moves-to-block-compounding-of-obesity-drug-ingredients-b15403 2026-05-01 weekly 0.8 https://blogpharma.com/article/iterative-health-raises-77m-to-expand-ai-clinical-research-platform-933608 2026-05-01 weekly 0.8 https://blogpharma.com/article/summit-therapeutics-stock-falls-on-ivonescimab-phase-3-setback-bb3b3d 2026-05-01 weekly 0.8 https://blogpharma.com/article/amgen-revises-tavneos-labeling-while-fda-pressure-intensifies-5bd7ea 2026-05-01 weekly 0.8 https://blogpharma.com/article/three-biotech-ipos-raise-over-850m-led-by-avalyns-strong-debut-28a49b 2026-05-01 weekly 0.8 https://blogpharma.com/article/industry-tackles-safety-hurdles-in-cell-and-gene-therapy-growth-fc8008 2026-05-01 weekly 0.8 https://blogpharma.com/article/fda-charts-new-path-for-personalized-gene-therapies-e897ba 2026-05-01 weekly 0.8 https://blogpharma.com/article/non-viral-gene-delivery-advances-toward-clinical-translation-ee7f5c 2026-05-01 weekly 0.8 https://blogpharma.com/article/blood-brain-barrier-remains-central-challenge-in-neurology-drug-development-dd11e1 2026-05-01 weekly 0.8 https://blogpharma.com/article/gene-editing-industry-confronts-scale-challenge-beyond-rare-diseases-bb6e6f 2026-05-01 weekly 0.8 https://blogpharma.com/article/engineering-better-viral-vectors-to-unlock-gene-therapys-potential-e60afe 2026-05-01 weekly 0.8 https://blogpharma.com/article/cell-and-gene-therapy-manufacturing-shifts-gears-for-commercial-scale-1c51ad 2026-05-01 weekly 0.8 https://blogpharma.com/article/bioaegis-eyes-inflammation-control-without-immune-suppression-c0bee3 2026-05-01 weekly 0.8 https://blogpharma.com/article/usp-charts-course-for-next-generation-biologics-standards-0d9e08 2026-05-01 weekly 0.8 https://blogpharma.com/article/drug-discovery-teams-lose-hours-to-poor-workflow-infrastructure-6ce9a8 2026-05-01 weekly 0.8 https://blogpharma.com/article/johnson-johnson-discontinues-two-car-t-lymphoma-programs-8bbff7 2026-05-01 weekly 0.8 https://blogpharma.com/article/boehringer-names-pharma-executive-to-lead-us-corporate-affairs-6b5fb8 2026-05-01 weekly 0.8 https://blogpharma.com/article/biomerieux-launches-rapid-mycoplasma-detection-platform-for-drug-manufacturing-8ead9d 2026-05-01 weekly 0.8 https://blogpharma.com/article/alfa-laval-launches-ensaline-agitator-for-pharmaceutical-manufacturing-a5d096 2026-05-01 weekly 0.8 https://blogpharma.com/article/thermo-fisher-launches-closed-system-fill-finish-platform-for-cell-therapies-7097ee 2026-05-01 weekly 0.8 https://blogpharma.com/article/leica-launches-scape-light-sheet-microscope-for-live-cell-imaging-96caa8 2026-05-01 weekly 0.8 https://blogpharma.com/article/revvity-launches-cloud-platform-for-molecular-cloning-operations-b2dcf0 2026-05-01 weekly 0.8 https://blogpharma.com/article/n6-launches-compact-thermocycler-for-smaller-scale-sequencing-labs-f750c6 2026-05-01 weekly 0.8 https://blogpharma.com/article/corcepts-als-candidate-shows-long-term-survival-gain-despite-trial-setback-6f4151 2026-05-01 weekly 0.8 https://blogpharma.com/article/fragmented-trial-tech-inflates-costs-by-nearly-half-industry-data-shows-6b4649 2026-05-01 weekly 0.8 https://blogpharma.com/article/fragmented-tech-systems-drive-clinical-trial-costs-up-45-percent-f3f9f1 2026-05-01 weekly 0.8 https://blogpharma.com/article/saudi-arabia-positions-itself-as-regional-clinical-trial-gateway-b57c9c 2026-05-01 weekly 0.8 https://blogpharma.com/article/saudi-arabia-establishes-itself-as-regional-clinical-research-destination-bfe744 2026-05-01 weekly 0.8 https://blogpharma.com/article/bambusa-reaches-full-enrollment-in-atopic-dermatitis-study-fefa0b 2026-05-01 weekly 0.8 https://blogpharma.com/article/axsome-wins-fda-greenlight-for-auvelity-in-alzheimers-agitation-d6550f 2026-05-01 weekly 0.8 https://blogpharma.com/article/eli-lilly-raises-full-year-revenue-outlook-on-strong-q1-performance-a24bac 2026-05-01 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibb-eyes-critical-data-in-q1-2026-71cc52 2026-05-01 weekly 0.8 https://blogpharma.com/article/merck-kgaa-advances-enpatoran-into-phase-iii-for-lupus-skin-disease-eb226e 2026-05-01 weekly 0.8 https://blogpharma.com/article/leo-pharma-expands-into-gene-therapy-with-replay-acquisition-c74649 2026-05-01 weekly 0.8 https://blogpharma.com/article/cannabis-leaf-chemistry-reveals-novel-compounds-with-therapeutic-promise-0011df 2026-05-01 weekly 0.8 https://blogpharma.com/article/biotech-ipo-activity-accelerates-with-556m-in-fresh-funding-2c1b17 2026-05-01 weekly 0.8 https://blogpharma.com/article/new-ai-model-predicts-gene-expression-changes-with-high-accuracy-df011c 2026-05-01 weekly 0.8 https://blogpharma.com/article/researchers-engineer-cas12a-system-for-targeted-rna-cleavage-596890 2026-05-01 weekly 0.8 https://blogpharma.com/article/glucose-distribution-guides-timing-of-brain-cell-myelination-6a9273 2026-04-30 weekly 0.8 https://blogpharma.com/article/j-craig-venter-genomics-pioneer-dies-at-79-c3c15e 2026-04-30 weekly 0.8 https://blogpharma.com/article/fda-appoints-szarama-as-interim-leader-of-biologics-center-a89570 2026-04-30 weekly 0.8 https://blogpharma.com/article/genomics-visionary-j-craig-venter-dies-at-79-c04eef 2026-04-30 weekly 0.8 https://blogpharma.com/article/fda-oncology-panel-rejects-astrazenecas-oral-serd-efficacy-claims-5205b7 2026-04-30 weekly 0.8 https://blogpharma.com/article/fda-clears-novel-dementia-agitation-treatment-avoiding-antipsychotic-class-39cc8e 2026-04-30 weekly 0.8 https://blogpharma.com/article/bristol-myers-squibbs-krazati-stumbles-in-colorectal-cancer-confirmatory-study-275899 2026-04-30 weekly 0.8 https://blogpharma.com/article/congressional-committee-seeks-fda-ban-on-china-generated-trial-data-297b99 2026-04-30 weekly 0.8 https://blogpharma.com/article/neural-mapping-technology-reveals-seizure-precursors-in-epilepsy-patients-3be702 2026-04-30 weekly 0.8 https://blogpharma.com/article/lillys-empower-lawsuit-partially-survives-early-dismissal-motion-590666 2026-04-30 weekly 0.8 https://blogpharma.com/article/supreme-court-signals-caution-on-generic-drug-label-restrictions-8ae759 2026-04-30 weekly 0.8 https://blogpharma.com/article/merck-maintains-confidence-in-terns-leukemia-acquisition-despite-data-concerns-8f1986 2026-04-30 weekly 0.8 https://blogpharma.com/article/uniqure-pursues-uk-regulatory-path-for-huntingtons-gene-therapy-86ec05 2026-04-30 weekly 0.8 https://blogpharma.com/article/fda-moves-to-block-compounders-from-producing-glp-1-weight-loss-drugs-371a15 2026-04-30 weekly 0.8 https://blogpharma.com/article/gut-pathogen-hijacks-host-metabolism-to-trigger-infection-and-disease-99a3fb 2026-04-30 weekly 0.8 https://blogpharma.com/article/preclinical-five-mechanism-obesity-therapy-shows-promise-in-rodent-models-5edc2d 2026-04-30 weekly 0.8 https://blogpharma.com/article/aav-gene-therapy-achieves-sustained-shiv-suppression-in-primates-c513e1 2026-04-30 weekly 0.8 https://blogpharma.com/article/avalyn-biotech-prices-300m-nasdaq-ipo-at-18-per-share-8ac400 2026-04-30 weekly 0.8 https://blogpharma.com/article/bristol-myers-poised-for-critical-data-year-street-eyes-key-trials-fede1d 2026-04-30 weekly 0.8 https://blogpharma.com/article/eli-lilly-beats-expectations-as-international-mounjaro-growth-accelerates-0bf365 2026-04-30 weekly 0.8 https://blogpharma.com/article/xtl-biopharmaceuticals-enters-psychedelics-space-with-psyga-bio-acquisition-20bc3d 2026-04-30 weekly 0.8 https://blogpharma.com/article/eliquis-faces-historic-revenue-erosion-as-exclusivity-expires-15eab1 2026-04-30 weekly 0.8 https://blogpharma.com/article/boston-health-tech-summit-reveals-investor-appetite-for-digital-solutions-3a65c9 2026-04-30 weekly 0.8 https://blogpharma.com/article/ai-and-data-science-tools-poised-to-reshape-clinical-research-operations-e1cea1 2026-04-30 weekly 0.8 https://blogpharma.com/article/fda-moves-to-bar-compounding-of-three-glp-1-drugs-040ace 2026-04-30 weekly 0.8 https://blogpharma.com/article/astrazeneca-revives-u-k-r-d-push-with-400m-cambridge-investment-7387cd 2026-04-30 weekly 0.8 https://blogpharma.com/article/cvs-explores-clinical-ai-but-cites-implementation-barriers-27467c 2026-04-30 weekly 0.8 https://blogpharma.com/article/scotlands-emerging-biotech-leaders-reshape-life-sciences-landscape-ea4cd7 2026-04-30 weekly 0.8 https://blogpharma.com/article/ecolab-opens-first-asian-bioprocessing-lab-in-south-korea-999ec3 2026-04-30 weekly 0.8 https://blogpharma.com/article/lillys-obesity-drug-faces-sluggish-launch-versus-novo-nordisk-065b68 2026-04-30 weekly 0.8 https://blogpharma.com/article/big-pharmas-r-d-spending-shows-uneven-returns-across-pipeline-5a6adc 2026-04-30 weekly 0.8 https://blogpharma.com/article/safety-review-clears-newrons-schizophrenia-study-to-resume-a3ac2a 2026-04-30 weekly 0.8 https://blogpharma.com/article/novartis-completes-23b-us-investment-map-with-north-carolina-plant-431e44 2026-04-30 weekly 0.8 https://blogpharma.com/article/chiesi-acquires-kalvista-for-1-9b-to-bolster-rare-disease-pipeline-de208c 2026-04-30 weekly 0.8 https://blogpharma.com/article/pfizers-elrexfio-shows-promise-for-earlier-multiple-myeloma-treatment-f1e5cd 2026-04-30 weekly 0.8 https://blogpharma.com/article/teva-pays-900m-for-emalex-to-strengthen-late-stage-portfolio-521b1a 2026-04-30 weekly 0.8 https://blogpharma.com/article/european-joint-clinical-assessment-faces-early-implementation-hurdles-fd8474 2026-04-30 weekly 0.8 https://blogpharma.com/article/european-joint-clinical-assessment-program-faces-early-growing-pains-58f509 2026-04-30 weekly 0.8 https://blogpharma.com/article/electronic-source-data-streamlines-trial-economics-and-timelines-5ae225 2026-04-30 weekly 0.8 https://blogpharma.com/article/newleos-advances-taar1-candidate-into-phase-ib-for-alcohol-use-disorder-cf90cf 2026-04-30 weekly 0.8 https://blogpharma.com/article/male-infertility-drug-development-faces-enrollment-barriers-3c7ea7 2026-04-30 weekly 0.8 https://blogpharma.com/article/ray-therapeutics-gains-ema-priority-review-for-retinitis-pigmentosa-gene-therapy-ee8a5e 2026-04-30 weekly 0.8 https://blogpharma.com/article/precision-biosciences-opens-function-dmd-trial-for-gene-therapy-candidate-d6c886 2026-04-30 weekly 0.8 https://blogpharma.com/article/regeneron-reports-earnings-decline-in-first-quarter-a79a7e 2026-04-30 weekly 0.8 https://blogpharma.com/article/epicrispr-pioneers-non-cutting-crispr-gene-editing-approach-d35263 2026-04-30 weekly 0.8 https://blogpharma.com/article/aerobic-exercise-emerges-as-gold-standard-for-knee-osteoarthritis-2bb807 2026-04-30 weekly 0.8 https://blogpharma.com/article/avalyn-raises-300m-to-reformulate-pulmonary-fibrosis-treatments-1dcda2 2026-04-30 weekly 0.8 https://blogpharma.com/article/removing-eye-barrier-unlocks-stem-cell-vision-restoration-potential-214538 2026-04-30 weekly 0.8 https://blogpharma.com/article/biomedical-foundation-models-reshape-drug-discovery-landscape-014289 2026-04-30 weekly 0.8 https://blogpharma.com/article/supreme-court-signals-support-for-generic-skinny-labeling-strategy-fbe9bd 2026-04-29 weekly 0.8 https://blogpharma.com/article/abbvie-defends-skyrizi-against-mounting-johnson-johnson-competition-fec58f 2026-04-29 weekly 0.8 https://blogpharma.com/article/fda-schedules-first-oncology-advisory-panel-in-nine-months-95aae1 2026-04-29 weekly 0.8 https://blogpharma.com/article/mcgill-researchers-engineer-mechanically-superior-blood-clots-using-click-chemis-a11179 2026-04-29 weekly 0.8 https://blogpharma.com/article/digital-twins-offer-incremental-supply-chain-gains-for-pharma-8af8f5 2026-04-29 weekly 0.8 https://blogpharma.com/article/milk-derived-exosomes-emerge-as-novel-bioprocessing-platform-936bd6 2026-04-29 weekly 0.8 https://blogpharma.com/article/enzyme-based-oligonucleotide-synthesis-gains-traction-as-sustainable-alternative-82b0c3 2026-04-29 weekly 0.8 https://blogpharma.com/article/pfizer-secures-patent-extension-for-vyndamax-through-2031-90637b 2026-04-29 weekly 0.8 https://blogpharma.com/article/boehringer-ingelheims-obesity-treatment-rivals-novos-wegovy-in-early-data-df2611 2026-04-29 weekly 0.8 https://blogpharma.com/article/teva-bolsters-neurology-portfolio-with-700m-emalex-acquisition-bd6956 2026-04-29 weekly 0.8 https://blogpharma.com/article/chiesi-acquires-kalvista-for-1-9-billion-in-rare-disease-play-ee3fab 2026-04-29 weekly 0.8 https://blogpharma.com/article/fda-pilots-live-data-monitoring-in-clinical-trials-48f724 2026-04-29 weekly 0.8 https://blogpharma.com/article/chiesi-acquires-kalvista-for-1-9b-fda-accelerates-drug-reviews-8138a1 2026-04-29 weekly 0.8 https://blogpharma.com/article/blood-pressure-control-shows-cv-benefit-across-ckd-populations-336227 2026-04-29 weekly 0.8 https://blogpharma.com/article/fda-pilots-real-time-data-platform-to-accelerate-clinical-trial-reviews-e367fd 2026-04-29 weekly 0.8 https://blogpharma.com/article/degrader-antibody-conjugates-gain-momentum-as-novel-drug-class-28857b 2026-04-29 weekly 0.8 https://blogpharma.com/article/fda-completes-unprecedented-infant-formula-safety-testing-program-0bbda3 2026-04-29 weekly 0.8 https://blogpharma.com/article/eli-lilly-invests-2-25b-in-ai-powered-gene-editing-partnership-7d71ce 2026-04-29 weekly 0.8 https://blogpharma.com/article/cdmos-ramp-up-manufacturing-infrastructure-for-potent-oncology-compounds-0dab38 2026-04-29 weekly 0.8 https://blogpharma.com/article/in-vivo-car-t-therapies-gain-traction-among-major-pharma-players-a5cda5 2026-04-29 weekly 0.8 https://blogpharma.com/article/australia-achieves-trachoma-elimination-milestone-who-confirms-f09745 2026-04-29 weekly 0.8 https://blogpharma.com/article/legacy-sleeping-sickness-drug-emerges-as-babs-treatment-5b6dcf 2026-04-29 weekly 0.8 https://blogpharma.com/article/researchers-develop-method-to-fine-tune-mrna-vaccine-immune-responses-c37cad 2026-04-29 weekly 0.8 https://blogpharma.com/article/hepatocyte-avoidance-boosts-mrna-vaccine-potency-in-new-study-e50757 2026-04-29 weekly 0.8 https://blogpharma.com/article/activists-challenge-trump-administration-over-gilead-hiv-patent-settlement-e2d027 2026-04-28 weekly 0.8 https://blogpharma.com/article/fda-pilots-real-time-data-monitoring-to-accelerate-clinical-trial-timelines-c00dc4 2026-04-28 weekly 0.8 https://blogpharma.com/article/fda-advances-real-time-clinical-trial-infrastructure-through-new-initiative-c43528 2026-04-28 weekly 0.8 https://blogpharma.com/article/fda-eyes-real-time-data-to-accelerate-drug-development-timelines-99aa40 2026-04-28 weekly 0.8 https://blogpharma.com/article/pfizer-secures-extended-exclusivity-for-tafamidis-through-settlement-deals-34889c 2026-04-28 weekly 0.8 https://blogpharma.com/article/boehringers-dual-action-obesity-drug-achieves-phase-3-success-1e8cd2 2026-04-28 weekly 0.8 https://blogpharma.com/article/supreme-court-to-weigh-generic-drug-skinny-label-strategy-26357c 2026-04-28 weekly 0.8 https://blogpharma.com/article/ubc-researchers-develop-novel-prostate-cancer-inhibitors-targeting-disordered-pr-247a33 2026-04-28 weekly 0.8 https://blogpharma.com/article/magnetic-microrobots-enable-damage-free-assembly-of-tissue-spheroids-acdc48 2026-04-28 weekly 0.8 https://blogpharma.com/article/rocket-pharmaceuticals-nets-180m-from-priority-review-voucher-sale-484987 2026-04-28 weekly 0.8 https://blogpharma.com/article/beone-medicines-acquires-trispecific-antibody-candidate-for-oncology-956af7 2026-04-28 weekly 0.8 https://blogpharma.com/article/incyte-advances-jak-inhibitor-for-vitiligo-after-phase-3-success-9839c9 2026-04-28 weekly 0.8 https://blogpharma.com/article/fda-alleges-data-manipulation-in-amgens-tavneos-development-519345 2026-04-28 weekly 0.8 https://blogpharma.com/article/boehringers-obesity-candidate-shows-modest-weight-loss-in-early-data-b38981 2026-04-28 weekly 0.8 https://blogpharma.com/article/abbvie-acquires-option-to-enter-pan-ras-oncology-market-b036bc 2026-04-28 weekly 0.8 https://blogpharma.com/article/novartis-ceo-warns-trumps-drug-pricing-model-threatens-innovation-53b337 2026-04-28 weekly 0.8 https://blogpharma.com/article/fda-escalates-move-against-chemocentryx-over-tavneos-trial-data-725582 2026-04-28 weekly 0.8 https://blogpharma.com/article/devoted-health-reports-first-revenue-decline-as-medicare-advantage-market-pressu-ca61d5 2026-04-28 weekly 0.8 https://blogpharma.com/article/coultreon-raises-125m-for-galapagos-licensed-immune-therapy-72434d 2026-04-28 weekly 0.8 https://blogpharma.com/article/adaptyv-bio-showcases-ai-protein-design-competition-results-5ae875 2026-04-28 weekly 0.8 https://blogpharma.com/article/eli-lilly-doubles-down-on-recombinase-gene-editing-platform-9a14f3 2026-04-28 weekly 0.8 https://blogpharma.com/article/galapagos-backed-coultreon-lands-125m-to-pursue-sik-inhibitors-840ede 2026-04-28 weekly 0.8 https://blogpharma.com/article/merck-kgaa-partners-with-remepy-on-integrated-cancer-therapies-5ef66e 2026-04-28 weekly 0.8 https://blogpharma.com/article/eli-lilly-partners-with-ai-biotech-on-advanced-gene-editing-platform-600e0c 2026-04-28 weekly 0.8 https://blogpharma.com/article/emerging-biotech-firms-challenge-traditional-exit-strategy-model-6c1807 2026-04-28 weekly 0.8 https://blogpharma.com/article/veradermics-reports-positive-phase-ii-iii-results-for-hair-loss-candidate-8f03d3 2026-04-28 weekly 0.8 https://blogpharma.com/article/novartis-warns-against-germanys-massive-healthcare-spending-reductions-ee5eb9 2026-04-28 weekly 0.8 https://blogpharma.com/article/boehringer-zealand-obesity-drug-shows-competitive-but-mixed-efficacy-data-d54097 2026-04-28 weekly 0.8 https://blogpharma.com/article/two-biotech-firms-plan-180m-combined-public-offerings-7ae67a 2026-04-28 weekly 0.8 https://blogpharma.com/article/compass-shares-plunge-following-disappointing-survival-data-bf8592 2026-04-28 weekly 0.8 https://blogpharma.com/article/cellenkos-advances-aplastic-anemia-program-with-phase-ii-green-light-1364ce 2026-04-28 weekly 0.8 https://blogpharma.com/article/research-links-shortened-pregnancy-duration-to-autism-risk-gradient-a047a7 2026-04-28 weekly 0.8 https://blogpharma.com/article/biomarin-closes-4-8b-amicus-therapeutics-acquisition-29fc77 2026-04-28 weekly 0.8 https://blogpharma.com/article/orukas-experimental-psoriasis-therapy-shows-promise-in-phase-iia-study-0be49c 2026-04-28 weekly 0.8 https://blogpharma.com/article/astrazeneca-gains-fda-nod-for-saphnelo-self-injection-formulation-d7fa67 2026-04-28 weekly 0.8 https://blogpharma.com/article/who-reports-hepatitis-progress-but-warns-2030-targets-at-risk-d25523 2026-04-28 weekly 0.8 https://blogpharma.com/article/novel-enzyme-discovery-promises-to-enhance-glp-1-receptor-agonist-durability-067abb 2026-04-28 weekly 0.8 https://blogpharma.com/article/regenerons-gene-therapy-becomes-first-fda-approved-treatment-for-genetic-deafnes-1221b6 2026-04-28 weekly 0.8 https://blogpharma.com/article/aav-production-methods-generate-unexpected-genetic-recombination-events-1fd222 2026-04-28 weekly 0.8 https://blogpharma.com/article/ai-optimizes-lipid-nanoparticles-for-precise-mrna-tissue-targeting-15481b 2026-04-28 weekly 0.8 https://blogpharma.com/article/retron-based-editing-tool-breaks-through-e-coli-barrier-1b21f9 2026-04-27 weekly 0.8 https://blogpharma.com/article/erasca-accelerates-ras-drug-data-release-amid-competitive-pressure-0214a5 2026-04-27 weekly 0.8 https://blogpharma.com/article/sun-pharma-to-acquire-organon-for-11-75-billion-9fd0d3 2026-04-27 weekly 0.8 https://blogpharma.com/article/uk-bowel-cancer-screening-expands-access-through-at-home-testing-8c5ae1 2026-04-27 weekly 0.8 https://blogpharma.com/article/mit-researchers-harness-laser-self-organization-for-advanced-brain-imaging-7321b9 2026-04-27 weekly 0.8 https://blogpharma.com/article/mit-laser-breakthrough-could-accelerate-brain-drug-development-4e5df9 2026-04-27 weekly 0.8 https://blogpharma.com/article/revolution-medicines-takes-legal-action-against-erasca-over-patent-disputes-ff16f9 2026-04-27 weekly 0.8 https://blogpharma.com/article/utah-medical-board-seeks-halt-to-ai-prescription-refill-program-79ea62 2026-04-27 weekly 0.8 https://blogpharma.com/article/researchers-identify-vulnerability-in-tumor-associated-senescent-cells-9e2288 2026-04-27 weekly 0.8 https://blogpharma.com/article/medtronic-boston-scientific-abbott-unveil-pfa-trial-results-24ac57 2026-04-27 weekly 0.8 https://blogpharma.com/article/orukas-experimental-psoriasis-candidate-demonstrates-enhanced-potency-in-mid-sta-43a61e 2026-04-27 weekly 0.8 https://blogpharma.com/article/veradermics-oral-minoxidil-shows-promise-for-hair-loss-treatment-4b83ad 2026-04-27 weekly 0.8 https://blogpharma.com/article/malaria-mosquito-in-americas-developing-drug-resistance-0a9c3e 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellias-crispr-gene-edit-clears-late-stage-hereditary-angioedema-study-959c30 2026-04-27 weekly 0.8 https://blogpharma.com/article/eli-lilly-pays-2-3b-for-blood-cancer-developer-ajax-therapeutics-2fb599 2026-04-27 weekly 0.8 https://blogpharma.com/article/pharmaceutical-companies-demonstrate-financial-returns-from-ai-adoption-1905e2 2026-04-27 weekly 0.8 https://blogpharma.com/article/thermo-fisher-divests-microbiology-unit-to-european-pe-firm-293ce2 2026-04-27 weekly 0.8 https://blogpharma.com/article/thermo-fisher-to-host-webinar-on-mab-downstream-processing-optimization-25ea02 2026-04-27 weekly 0.8 https://blogpharma.com/article/pharma-shifts-ai-governance-as-artificial-intelligence-becomes-core-operation-24b8c8 2026-04-27 weekly 0.8 https://blogpharma.com/article/pritelivir-shows-promise-in-hard-to-treat-immunocompromised-hsv-cases-a93fe9 2026-04-27 weekly 0.8 https://blogpharma.com/article/pritelivir-shows-promise-for-drug-resistant-hsv-in-immunocompromised-patients-db0867 2026-04-27 weekly 0.8 https://blogpharma.com/article/nordic-drug-pricing-under-pressure-as-us-most-favored-nation-policy-reshapes-eur-feb776 2026-04-27 weekly 0.8 https://blogpharma.com/article/eli-lilly-acquires-ajax-for-jak-inhibitor-myelofibrosis-portfolio-e350aa 2026-04-27 weekly 0.8 https://blogpharma.com/article/orukas-psoriasis-candidate-shows-promise-against-skyrizi-d188b5 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellias-crispr-therapy-clears-late-stage-hae-study-ce9c7a 2026-04-27 weekly 0.8 https://blogpharma.com/article/whitehead-researchers-optimize-gene-therapy-delivery-through-producer-cell-engin-cf3c1b 2026-04-27 weekly 0.8 https://blogpharma.com/article/astellas-advances-next-generation-gene-therapy-after-prior-setback-f8b69e 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellias-in-vivo-crispr-therapy-shows-promise-in-hae-trial-d1bc5a 2026-04-27 weekly 0.8 https://blogpharma.com/article/who-tests-global-pandemic-response-with-simulation-exercise-f4fb6e 2026-04-27 weekly 0.8 https://blogpharma.com/article/gilead-charts-diversification-course-as-hiv-revenue-matures-3305f8 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellias-in-vivo-gene-edit-clears-phase-3-for-rare-swelling-disease-42777b 2026-04-27 weekly 0.8 https://blogpharma.com/article/brain-region-identified-as-control-hub-for-chronic-pain-development-761e2a 2026-04-27 weekly 0.8 https://blogpharma.com/article/lilly-deploys-glp-1-profits-in-2-3b-jak-inhibitor-acquisition-131d40 2026-04-27 weekly 0.8 https://blogpharma.com/article/compass-reports-secondary-data-from-biliary-cancer-bispecific-study-b129ff 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellia-achieves-phase-3-win-with-in-vivo-crispr-gene-editor-7647c4 2026-04-27 weekly 0.8 https://blogpharma.com/article/intellias-in-vivo-crispr-therapy-shows-promise-for-hereditary-angioedema-980ba9 2026-04-27 weekly 0.8 https://blogpharma.com/article/veradermics-achieves-phase-2-3-win-for-oral-hair-loss-treatment-2a58a9 2026-04-27 weekly 0.8 https://blogpharma.com/article/fathom-secures-47m-series-a-after-rebranding-from-atommap-2f5b8d 2026-04-27 weekly 0.8 https://blogpharma.com/article/novartis-gains-european-approval-and-who-seal-for-two-key-medicines-186ef4 2026-04-27 weekly 0.8 https://blogpharma.com/article/british-biotech-sector-shows-capital-momentum-in-early-2026-b9a8b1 2026-04-27 weekly 0.8 https://blogpharma.com/article/ascletis-finishes-enrolling-phase-ii-study-of-asc30-diabetes-treatment-84d1e8 2026-04-27 weekly 0.8 https://blogpharma.com/article/sun-pharma-agrees-to-acquire-organon-in-11-75b-cash-deal-4b48ab 2026-04-27 weekly 0.8 https://blogpharma.com/article/body-movement-drives-brain-fluid-cleansing-penn-state-study-reveals-420b65 2026-04-27 weekly 0.8 https://blogpharma.com/article/kyowa-kirin-and-kura-launch-japanese-phase-ii-study-of-ziftomenib-ad4e72 2026-04-27 weekly 0.8 https://blogpharma.com/article/ai-tools-tackle-data-bottleneck-in-single-cell-research-f8b38f 2026-04-27 weekly 0.8 https://blogpharma.com/article/sun-pharma-acquires-organon-for-11-75b-to-strengthen-womens-health-abf2c6 2026-04-27 weekly 0.8 https://blogpharma.com/article/new-algorithm-boosts-accuracy-of-metagenome-assembly-and-classification-db356c 2026-04-27 weekly 0.8 https://blogpharma.com/article/uk-biotech-funding-rebounds-after-extended-slowdown-766c50 2026-04-26 weekly 0.8 https://blogpharma.com/article/trump-executive-order-catalyzes-market-rally-in-psychedelic-drug-developers-43848f 2026-04-26 weekly 0.8 https://blogpharma.com/article/graphene-oxide-shows-selective-bacterial-killing-without-harming-human-tissue-32bb10 2026-04-26 weekly 0.8 https://blogpharma.com/article/harvard-researchers-identify-gut-bacteria-link-to-depression-via-inflammation-af5ec3 2026-04-25 weekly 0.8 https://blogpharma.com/article/lilly-bolsters-cell-therapy-portfolio-sanofi-faces-immunology-challenges-9eda19 2026-04-25 weekly 0.8 https://blogpharma.com/article/mechanical-properties-of-cells-may-signal-breast-cancer-risk-c1c7c1 2026-04-24 weekly 0.8 https://blogpharma.com/article/biomarkers-gain-ground-as-clinical-trial-endpoints-says-bms-scientist-f7007b 2026-04-24 weekly 0.8 https://blogpharma.com/article/biomarkers-face-long-road-to-regulatory-acceptance-as-trial-endpoints-44e94d 2026-04-24 weekly 0.8 https://blogpharma.com/article/single-cell-study-maps-how-down-syndrome-alters-prenatal-brain-development-d6d058 2026-04-24 weekly 0.8 https://blogpharma.com/article/paris-biotech-one-biosciences-establishes-first-u-s-hub-in-albany-1d3ec4 2026-04-24 weekly 0.8 https://blogpharma.com/article/fda-accelerates-psychedelic-drug-reviews-under-new-mental-health-initiative-a7e6ee 2026-04-24 weekly 0.8 https://blogpharma.com/article/fda-awards-fast-track-vouchers-to-three-psychedelic-developers-8ce419 2026-04-24 weekly 0.8 https://blogpharma.com/article/who-approves-first-infant-specific-malaria-drug-ahead-of-key-health-milestone-e7ab57 2026-04-24 weekly 0.8 https://blogpharma.com/article/tavapadons-latest-data-bolsters-path-to-parkinsons-market-46078c 2026-04-24 weekly 0.8 https://blogpharma.com/article/ai-adoption-accelerates-in-oncology-biotech-m-a-remains-robust-ddc24b 2026-04-24 weekly 0.8 https://blogpharma.com/article/qulipta-demonstrates-edge-over-rival-in-migraine-prevention-study-b191fd 2026-04-24 weekly 0.8 https://blogpharma.com/article/tenpoint-therapeutics-names-lane-as-chief-medical-officer-4183de 2026-04-24 weekly 0.8 https://blogpharma.com/article/european-regulators-back-sanofis-ms-candidate-despite-fda-setback-0aac92 2026-04-24 weekly 0.8 https://blogpharma.com/article/symbravo-shows-sustained-efficacy-in-migraine-but-pricing-questions-persist-28bcca 2026-04-24 weekly 0.8 https://blogpharma.com/article/avalyn-pharma-eyes-182m-raise-in-upcoming-ipo-f3857e 2026-04-24 weekly 0.8 https://blogpharma.com/article/biogen-eyes-china-multiple-myeloma-market-with-850m-felzartamab-acquisition-7b9819 2026-04-24 weekly 0.8 https://blogpharma.com/article/first-malaria-trial-in-early-pregnancy-breaks-recruitment-barriers-e0cde7 2026-04-24 weekly 0.8 https://blogpharma.com/article/novartis-retreats-on-pluvicto-expansion-in-european-market-ed1d7b 2026-04-24 weekly 0.8 https://blogpharma.com/article/eli-lilly-shares-slip-amid-foundayo-launch-uncertainty-68c034 2026-04-24 weekly 0.8 https://blogpharma.com/article/solengepras-shows-promise-in-early-parkinsons-disease-trial-7d8d77 2026-04-24 weekly 0.8 https://blogpharma.com/article/berkeley-team-explores-gene-therapy-route-for-sustained-weight-loss-4f3ae8 2026-04-24 weekly 0.8 https://blogpharma.com/article/ema-committee-backs-three-candidates-across-diverse-therapeutic-areas-b97d1a 2026-04-24 weekly 0.8 https://blogpharma.com/article/trump-secures-final-drug-pricing-deal-with-regeneron-a26488 2026-04-24 weekly 0.8 https://blogpharma.com/article/sanofi-ms-treatment-advances-in-europe-after-fda-setback-9d18e5 2026-04-24 weekly 0.8 https://blogpharma.com/article/fda-expedites-review-of-mental-illness-therapies-under-white-house-directive-d26689 2026-04-24 weekly 0.8 https://blogpharma.com/article/scientists-silence-extra-chromosome-21-using-engineered-crispr-9956a7 2026-04-24 weekly 0.8 https://blogpharma.com/article/japanese-pharma-shifts-strategy-outsourcing-peptide-development-earlier-10d0b7 2026-04-24 weekly 0.8 https://blogpharma.com/article/sanofis-ms-drug-advances-in-europe-despite-fda-setback-59101f 2026-04-24 weekly 0.8 https://blogpharma.com/article/ai-technology-sharpens-recruitment-retention-in-cardiometabolic-trials-d92cdd 2026-04-24 weekly 0.8 https://blogpharma.com/article/pfizer-strategy-chief-baum-departs-transitions-to-advisory-role-80d252 2026-04-24 weekly 0.8 https://blogpharma.com/article/nucleus-network-minneapolis-advances-cardiometabolic-trial-capabilities-c95af2 2026-04-24 weekly 0.8 https://blogpharma.com/article/ozmosi-planview-integration-bridges-r-d-data-silos-fbe348 2026-04-24 weekly 0.8 https://blogpharma.com/article/epitopea-clears-uk-regulatory-hurdles-for-ovarian-cancer-study-2b15cb 2026-04-24 weekly 0.8 https://blogpharma.com/article/regeneron-strikes-white-house-agreement-on-drug-pricing-free-gene-therapy-access-1e8fe4 2026-04-24 weekly 0.8 https://blogpharma.com/article/daiichi-sankyo-delays-annual-results-announcement-shares-fall-98e71b 2026-04-24 weekly 0.8 https://blogpharma.com/article/catalym-launches-pivotal-trial-for-cachexia-targeting-antibody-3a4b7d 2026-04-24 weekly 0.8 https://blogpharma.com/article/cumberland-divests-commercial-portfolio-to-apotex-in-100m-deal-ee4d2a 2026-04-24 weekly 0.8 https://blogpharma.com/article/diagonal-therapeutics-advances-novel-antibody-platform-for-vascular-disorders-b7fcd4 2026-04-24 weekly 0.8 https://blogpharma.com/article/global-catch-up-vaccination-drive-surpasses-100-million-doses-103514 2026-04-24 weekly 0.8 https://blogpharma.com/article/enantas-rsv-candidate-shows-promise-in-high-risk-patient-population-bf58d9 2026-04-23 weekly 0.8 https://blogpharma.com/article/olorofim-shows-promise-against-invasive-aspergillus-in-blood-cancer-patients-ab016c 2026-04-23 weekly 0.8 https://blogpharma.com/article/in-vivo-lentiviral-manufacturing-faces-scalability-and-purity-hurdles-7880e3 2026-04-23 weekly 0.8 https://blogpharma.com/article/trump-completes-first-wave-of-pharmaceutical-pricing-negotiations-12ac28 2026-04-23 weekly 0.8 https://blogpharma.com/article/regeneron-scores-first-fda-win-under-gene-therapy-priority-voucher-program-af6296 2026-04-23 weekly 0.8 https://blogpharma.com/article/base-editing-strategy-targets-neglected-cystic-fibrosis-mutation-2717ff 2026-04-23 weekly 0.8 https://blogpharma.com/article/mechanical-force-of-heartbeat-may-block-tumor-development-7f2a0b 2026-04-23 weekly 0.8 https://blogpharma.com/article/fda-green-lights-inaugural-gene-therapy-for-hereditary-deafness-d0a899 2026-04-23 weekly 0.8 https://blogpharma.com/article/bluerocks-stem-cell-parkinsons-therapy-shows-encouraging-safety-profile-22cc94 2026-04-23 weekly 0.8 https://blogpharma.com/article/regeneron-receives-fda-nod-for-first-hearing-loss-gene-therapy-c675e5 2026-04-23 weekly 0.8 https://blogpharma.com/article/substance-use-disorder-biotech-tempero-shutters-operations-after-safety-incident-804b22 2026-04-23 weekly 0.8 https://blogpharma.com/article/trumps-cdc-director-pick-signals-tension-within-health-leadership-27e2b8 2026-04-23 weekly 0.8 https://blogpharma.com/article/radioligand-market-faces-first-generic-challenge-to-novartis-leader-5d0bfd 2026-04-23 weekly 0.8 https://blogpharma.com/article/regenerative-medicine-separates-clinical-reality-from-marketing-hype-376bb6 2026-04-23 weekly 0.8 https://blogpharma.com/article/abbvie-commits-1-4b-to-major-north-carolina-manufacturing-hub-f322c1 2026-04-23 weekly 0.8 https://blogpharma.com/article/state-legislatures-push-back-against-drug-pricing-board-restrictions-b822f2 2026-04-23 weekly 0.8 https://blogpharma.com/article/ai-integration-in-cancer-research-moves-from-promise-to-practice-795863 2026-04-23 weekly 0.8 https://blogpharma.com/article/non-animal-models-gain-traction-as-drug-development-tool-3d158b 2026-04-23 weekly 0.8 https://blogpharma.com/article/sanofi-leadership-transition-signals-potential-shift-in-r-d-strategy-b35411 2026-04-23 weekly 0.8 https://blogpharma.com/article/roche-bets-blockbuster-revenue-on-cancer-weight-loss-pipeline-b74fab 2026-04-23 weekly 0.8 https://blogpharma.com/article/half-million-uk-biobank-records-exposed-in-major-data-breach-5e9467 2026-04-23 weekly 0.8 https://blogpharma.com/article/amgen-cto-david-reese-steps-down-after-long-tenure-0e4cc1 2026-04-23 weekly 0.8 https://blogpharma.com/article/sanofi-navigates-r-d-challenges-amid-solid-q1-results-b0ed94 2026-04-23 weekly 0.8 https://blogpharma.com/article/silicon-valley-veteran-launches-healthcare-ai-residency-for-founders-3fcd35 2026-04-23 weekly 0.8 https://blogpharma.com/article/rfk-jr-moderates-stance-on-vaccines-pharma-industry-collaboration-ec7f0d 2026-04-23 weekly 0.8 https://blogpharma.com/article/novos-oral-glp-1-shows-efficacy-in-pediatric-type-2-diabetes-774389 2026-04-23 weekly 0.8 https://blogpharma.com/article/amneal-expands-biosimilar-footprint-with-375m-acquisition-cb9f62 2026-04-23 weekly 0.8 https://blogpharma.com/article/pharma-telehealth-partnerships-draw-regulatory-scrutiny-over-fee-structures-f8fcae 2026-04-23 weekly 0.8 https://blogpharma.com/article/cms-fda-launch-fast-track-coverage-for-breakthrough-devices-13be86 2026-04-23 weekly 0.8 https://blogpharma.com/article/algeria-achieves-trachoma-elimination-joins-29-nation-club-f38e81 2026-04-23 weekly 0.8 https://blogpharma.com/article/who-documents-significant-health-gains-in-2025-despite-budget-constraints-e9ebfb 2026-04-23 weekly 0.8 https://blogpharma.com/article/intestinal-procedure-shows-promise-in-sustaining-post-glp-1-weight-loss-c9a843 2026-04-23 weekly 0.8 https://blogpharma.com/article/deep-learning-advances-enable-sharper-live-tissue-imaging-3c728b 2026-04-23 weekly 0.8 https://blogpharma.com/article/retron-based-genome-editing-works-across-diverse-bacterial-species-059758 2026-04-23 weekly 0.8 https://blogpharma.com/article/bahamas-achieves-who-certification-for-eliminating-mother-to-child-hiv-transmiss-cc416c 2026-04-22 weekly 0.8 https://blogpharma.com/article/revolution-medicines-unveils-catalytic-ras-inhibitor-strategy-at-aacr-c31482 2026-04-22 weekly 0.8 https://blogpharma.com/article/revolutions-pancreatic-cancer-therapy-demonstrates-early-clinical-promise-6bb1ae 2026-04-22 weekly 0.8 https://blogpharma.com/article/moderna-advances-avian-influenza-vaccine-program-despite-earlier-federal-setback-c6b33b 2026-04-22 weekly 0.8 https://blogpharma.com/article/medicare-postpones-obesity-drug-coverage-pilot-as-political-plans-stall-f0d85c 2026-04-22 weekly 0.8 https://blogpharma.com/article/medicare-obesity-drug-access-bypasses-part-d-after-insurer-pushback-048777 2026-04-22 weekly 0.8 https://blogpharma.com/article/merck-invests-in-google-cloud-partnership-roche-advances-ms-candidate-66ac5f 2026-04-22 weekly 0.8 https://blogpharma.com/article/cancer-research-landscape-shifts-at-aacr-2026-conference-6761f5 2026-04-22 weekly 0.8 https://blogpharma.com/article/ai-powered-research-tool-reshapes-approach-to-drug-development-20a9b3 2026-04-22 weekly 0.8 https://blogpharma.com/article/gut-bacteriophage-discovery-may-explain-colorectal-cancer-link-0d78e5 2026-04-22 weekly 0.8 https://blogpharma.com/article/parp-inhibitors-establish-track-record-while-clinical-boundaries-emerge-f41749 2026-04-22 weekly 0.8 https://blogpharma.com/article/dual-drug-approach-shows-promise-against-fatty-liver-disease-a142c7 2026-04-22 weekly 0.8 https://blogpharma.com/article/new-method-enables-reference-free-analysis-of-barcoded-cell-data-c4f408 2026-04-22 weekly 0.8 https://blogpharma.com/article/plasma-proteomics-depth-gains-do-not-guarantee-data-quality-13da22 2026-04-22 weekly 0.8 https://blogpharma.com/article/supreme-court-ruling-clouds-synthetic-biology-regulatory-landscape-7df909 2026-04-22 weekly 0.8 https://blogpharma.com/article/roche-advances-ms-candidate-despite-emerging-safety-concerns-a6bdef 2026-04-21 weekly 0.8 https://blogpharma.com/article/revolution-medicines-advances-kras-pipeline-with-dual-data-at-aacr-843b52 2026-04-21 weekly 0.8 https://blogpharma.com/article/revolutions-kras-inhibitor-shows-durable-pancreatic-cancer-benefit-537f49 2026-04-21 weekly 0.8 https://blogpharma.com/article/pipeline-advances-promise-new-options-for-atopic-dermatitis-care-d7853d 2026-04-21 weekly 0.8 https://blogpharma.com/article/korean-skincare-ingredient-shows-potent-activity-against-resistant-bacteria-acac3d 2026-04-21 weekly 0.8 https://blogpharma.com/article/fda-marks-progress-on-alternative-testing-methods-initiative-5e814d 2026-04-20 weekly 0.8 https://blogpharma.com/article/amino-acid-modification-dramatically-enhances-mrna-nanoparticle-uptake-afba9e 2026-04-20 weekly 0.8 https://blogpharma.com/article/kinase-inhibitor-screening-maps-drug-repurposing-and-mutation-specific-opportuni-2ba25d 2026-04-20 weekly 0.8 https://blogpharma.com/article/hypoxic-ischemic-encephalopathy-treatment-advances-toward-first-approval-ed71d4 2026-04-17 weekly 0.8 https://blogpharma.com/article/bacteria-deploy-explosive-mechanism-to-share-antibiotic-resistance-cc268d 2026-04-17 weekly 0.8 https://blogpharma.com/article/argobio-spins-out-european-biotech-companies-from-leading-academic-centers-3769ef 2026-04-17 weekly 0.8 https://blogpharma.com/article/fda-clears-wearable-technology-for-pancreatic-cancer-monitoring-f8baaf 2026-04-17 weekly 0.8 https://blogpharma.com/article/researchers-engineer-car-t-cells-directly-inside-patient-bodies-e67da8 2026-04-17 weekly 0.8 https://blogpharma.com/article/fda-opens-door-to-testosterone-therapy-expansion-for-libido-d4a0a9 2026-04-16 weekly 0.8 https://blogpharma.com/article/long-term-ibs-drug-use-tied-to-elevated-mortality-risk-in-major-cohort-study-a79a1b 2026-04-16 weekly 0.8 https://blogpharma.com/article/metformin-shows-promise-for-reducing-insulin-requirements-in-type-1-diabetes-33cc7c 2026-04-16 weekly 0.8 https://blogpharma.com/article/eight-biotech-players-reshaping-allergy-treatment-landscape-62890a 2026-04-15 weekly 0.8 https://blogpharma.com/article/bridging-the-gap-between-academia-and-venture-capital-8e4271 2026-04-15 weekly 0.8 https://blogpharma.com/article/sudans-healthcare-system-deteriorates-amid-protracted-conflict-006f3f 2026-04-14 weekly 0.8 https://blogpharma.com/article/fda-releases-framework-for-evaluating-gene-editing-therapy-safety-2bb91d 2026-04-14 weekly 0.8 https://blogpharma.com/article/phage-therapy-emerges-as-potential-antibiotic-resistance-countermeasure-d037ee 2026-04-14 weekly 0.8 https://blogpharma.com/article/social-proximity-shapes-gut-microbiome-composition-in-shared-households-ce1018 2026-04-14 weekly 0.8 https://blogpharma.com/article/study-reveals-toilet-plume-risk-exceeds-direct-surface-contamination-19d278 2026-04-14 weekly 0.8 https://blogpharma.com/article/fda-issues-disclosure-reminder-to-over-2-200-trial-sponsors-754bf6 2026-04-13 weekly 0.8 https://blogpharma.com/article/targeted-toothpaste-formula-preserves-oral-microbiome-while-combating-periodonti-e33f51 2026-04-13 weekly 0.8 https://blogpharma.com/article/obesitys-divergent-health-impact-in-men-versus-women-uncovered-26d54f 2026-04-13 weekly 0.8 https://blogpharma.com/article/amgen-shifts-portfolio-strategy-as-legacy-drugs-face-decline-13989f 2026-04-13 weekly 0.8 https://blogpharma.com/article/genetic-variants-explain-treatment-resistance-to-glp-1-drugs-in-subset-of-patien-bbe3b0 2026-04-12 weekly 0.8 https://blogpharma.com/article/novel-airborne-chemical-contaminant-identified-in-u-s-atmosphere-00077f 2026-04-11 weekly 0.8 https://blogpharma.com/article/researchers-confirm-long-held-b1-chemistry-theory-through-molecular-stabilizatio-ab69d1 2026-04-11 weekly 0.8 https://blogpharma.com/article/march-m-a-surge-spans-small-molecules-to-monoclonal-antibodies-a8d780 2026-04-10 weekly 0.8 https://blogpharma.com/article/who-launches-inaugural-global-forum-for-800-research-institutions-013dec 2026-04-09 weekly 0.8 https://blogpharma.com/article/who-france-launch-coordinated-one-health-action-plan-a222c6 2026-04-07 weekly 0.8 https://blogpharma.com/article/who-launches-science-focused-campaign-for-world-health-day-2026-22b3fe 2026-04-06 weekly 0.8 https://blogpharma.com/article/fda-grants-first-nme-approval-under-priority-voucher-initiative-b465ef 2026-04-01 weekly 0.8 https://blogpharma.com/article/who-delays-pathogen-sharing-rules-pushes-decision-to-may-assembly-f4d4ef 2026-03-28 weekly 0.8 https://blogpharma.com/article/fda-clears-first-gene-therapy-for-rare-leukocyte-adhesion-disorder-35dfc1 2026-03-26 weekly 0.8 https://blogpharma.com/article/majority-of-nations-adopt-refugee-and-migrant-health-inclusion-policies-eabc94 2026-03-26 weekly 0.8 https://blogpharma.com/article/fda-clears-first-brain-penetrating-therapy-for-hunter-syndrome-1e4fc1 2026-03-25 weekly 0.8 https://blogpharma.com/article/who-pushes-point-of-care-tb-diagnostics-to-accelerate-disease-detection-ea1e17 2026-03-24 weekly 0.8 https://blogpharma.com/article/fda-opens-comment-period-on-priority-voucher-pilot-initiative-375b9a 2026-03-20 weekly 0.8 https://blogpharma.com/article/fda-green-lights-higher-dose-semaglutide-under-priority-voucher-initiative-bcb300 2026-03-19 weekly 0.8 https://blogpharma.com/article/fda-charts-path-for-non-animal-testing-methods-in-drug-development-80e2c7 2026-03-18 weekly 0.8 https://blogpharma.com/article/global-child-mortality-decline-stalls-despite-preventable-deaths-48d95a 2026-03-18 weekly 0.8 https://blogpharma.com/article/european-patient-groups-to-shape-rsv-and-maternal-vaccination-strategy-3a7265 2026-03-12 weekly 0.8 https://blogpharma.com/article/fda-debuts-unified-platform-for-real-time-safety-monitoring-88ea9c 2026-03-11 weekly 0.8 https://blogpharma.com/article/middle-east-conflict-creates-cascading-health-system-strain-9573f2 2026-03-11 weekly 0.8 https://blogpharma.com/article/fda-clears-wellcovorin-for-rare-cerebral-folate-transport-disorder-42544b 2026-03-10 weekly 0.8 https://blogpharma.com/article/eu-funded-initiative-convenes-brussels-lab-to-combat-vaccine-hesitancy-5fd2a2 2026-03-10 weekly 0.8 https://blogpharma.com/article/eu-respiratory-vaccination-strategy-gains-ground-amid-cvd-prevention-focus-fe8007 2026-03-10 weekly 0.8 https://blogpharma.com/article/chile-achieves-who-leprosy-elimination-verification-first-in-americas-b96def 2026-03-04 weekly 0.8 https://blogpharma.com/article/gene-therapy-redosing-emerges-as-key-challenge-for-future-development-372191 2026-01-09 weekly 0.8 https://blogpharma.com/article/wcg-report-maps-four-critical-shifts-reshaping-clinical-research-a66fb7 2026-01-05 weekly 0.8 https://blogpharma.com/article/in-vivo-gene-editing-gains-momentum-as-manufacturing-barriers-fall-b11a02 2025-12-23 weekly 0.8 https://blogpharma.com/article/european-groups-push-vaccination-policy-evolution-patient-engagement-49c9c1 2025-11-27 weekly 0.8 https://blogpharma.com/article/industry-survey-maps-ai-adoption-across-clinical-research-landscape-c3c276 2025-11-14 weekly 0.8 https://blogpharma.com/article/clinical-research-adopts-gender-inclusive-language-standards-4c0f1a 2025-11-11 weekly 0.8 https://blogpharma.com/article/healthcare-systems-face-readiness-gaps-for-car-t-cell-rollout-9c8e23 2025-10-29 weekly 0.8 https://blogpharma.com/article/fda-issues-guidance-on-global-oncology-trial-data-for-u-s-approvals-03ff22 2025-10-28 weekly 0.8 https://blogpharma.com/article/wcg-report-identifies-key-operational-hurdles-facing-clinical-research-sites-5f3bab 2025-10-27 weekly 0.8 https://blogpharma.com/article/advocacy-groups-push-eu-to-develop-comprehensive-respiratory-health-strategy-04725f 2025-10-02 weekly 0.8 https://blogpharma.com/article/eu-initiative-targets-adult-vaccination-gap-in-chronic-disease-populations-f3939e 2025-09-23 weekly 0.8 https://blogpharma.com/article/irish-cbd-market-matures-as-dr-hemp-me-sets-quality-standards-57fb6b 2025-09-17 weekly 0.8 https://blogpharma.com/article/consumer-wellness-content-misfiled-in-pharma-news-feed-202bb1 2025-09-12 weekly 0.8 https://blogpharma.com/article/cloud-software-platforms-expand-clinical-trial-access-beyond-large-sponsors-181db2 2025-08-26 weekly 0.8 https://blogpharma.com/article/saas-platforms-lower-clinical-trial-barriers-for-smaller-biotech-866264 2025-08-21 weekly 0.8 https://blogpharma.com/article/ich-updates-e6-r3-guidance-with-focus-on-stakeholder-collaboration-f869e1 2025-08-06 weekly 0.8 https://blogpharma.com/article/irish-wellness-market-embraces-chaga-despite-no-native-growth-c412a5 2025-07-03 weekly 0.8